Autophagy is an evolutionarily conserved biological process involved in an array of physiological and pathological events. Without proper control, autophagy contributes to various disorders, including cancer and autoimmune and inflammatory diseases. It is therefore of vital importance that autophagy is under careful balance. Thus, additional regulators undoubtedly deepen our understanding of the working network, and provide potential therapeutic targets for disorders. In this study, we found that RNF216 (ring finger protein 216), an E3 ubiquitin ligase, strongly inhibits autophagy in macrophages. Further exploration demonstrates that RNF216 interacts with BECN1, a key regulator in autophagy, and leads to ubiquitination of BECN1, thereby contributing to BECN1 degradation. RNF216 was involved in the ubiquitination of lysine 48 of BECN1 through direct interaction with the triad (2 RING fingers and a DRIL [double RING finger linked]) domain. We further showed that inhibition of autophagy through overexpression of RNF216 in alveolar macrophages promotes Listeria monocytogenes growth and distribution, while knockdown of RNF216 significantly inhibited these outcomes. These effects were confirmed in a mouse model of L. monocytogenes infection, suggesting that manipulating RNF216 expression could be a therapeutic approach. Thus, our study identifies a novel negative regulator of autophagy and suggests that RNF216 may be a target for treatment of inflammatory diseases.
Autophagy is an evolutionarily conserved biological process involved in an array of physiological and pathological events. Without proper control, autophagy contributes to various disorders, including cancer and autoimmune and inflammatory diseases. It is therefore of vital importance that autophagy is under careful balance. Thus, additional regulators undoubtedly deepen our understanding of the working network, and provide potential therapeutic targets for disorders. In this study, we found that RNF216 (ring finger protein 216), an E3 ubiquitin ligase, strongly inhibits autophagy in macrophages. Further exploration demonstrates that RNF216 interacts with BECN1, a key regulator in autophagy, and leads to ubiquitination of BECN1, thereby contributing to BECN1 degradation. RNF216 was involved in the ubiquitination of lysine 48 of BECN1 through direct interaction with the triad (2 RING fingers and a DRIL [double RING finger linked]) domain. We further showed that inhibition of autophagy through overexpression of RNF216 in alveolar macrophages promotes Listeria monocytogenes growth and distribution, while knockdown of RNF216 significantly inhibited these outcomes. These effects were confirmed in a mouse model of L. monocytogenesinfection, suggesting that manipulating RNF216expression could be a therapeutic approach. Thus, our study identifies a novel negative regulator of autophagy and suggests that RNF216 may be a target for treatment of inflammatory diseases.
Entities:
Keywords:
Atg, autophagy-related; BALF, bronchoalveolar lavage fluid; BECN1; BMDM, bone marrow-derived macrophage; CFU, colony-forming unit; GFP, green fluorescent protein; HRP, horseradish peroxidase; LPS, lipopolysaccharide; MAP1LC3A, microtubule-associated protein 1 light chain 3 α; MOI, multiplicity of infection; NFKB, nuclear factor of kappa light polypeptide gene enhancer in B-cells; PBS, phosphate-buffered saline; RIPK1, receptor (TNFRSF)-interacting serine-threonine kinase 1; RNF216; RNF216, ring finger protein 216;TIRAP, toll-interleukin 1 receptor (TIR) domain containing adaptor protein; TICAM1/TRIF, toll-like receptor adaptor molecule 1; TICAM2, toll-like receptor adaptor molecule 2; TLR, toll-like receptor; TNF, tumor necrosis factor; TRAF, TNF receptor-associated factor; Triad, 2 RING fingers and a DRIL (double RING finger linked); Ub, ubiquitin; autophagy; i.t., intratracheally; protein degradation; shRNA, short hairpin RNA; ubiquitination
Innate immunity is a highly conserved but highly effective first line of defense against pathogens, and plays an indispensable role in organism survival. The immune cells recognize the invaded pathogens through numerous pattern recognition receptors, among which toll-like receptors (TLRs) are the most-studied family. Upon activation, TLRs initiate NFKB (nuclear factor of kappa light polypeptide gene enhancer in B-cells) signaling and interferon regulatory transcription factor signaling cascade through MYD88 (myeloid differentiation primary response 88)-TIRAP (toll-interleukin 1 receptor [TIR] domain containing adaptor protein) or TICAM1/TRIF (toll-like receptor adaptor molecule 1)-TICAM2 (toll-like receptor adaptor molecule 2), and sequentially results in the production of various cytokines. Additionally, multiple TLRs induce autophagy, which is considered as an alternative form of innate immunity.Autophagy is a cellular autonomous process to maintain cellular homeostasis via the degradation of a cell's own cytosolic components or protein aggregates. Besides starvation, a myriad of extrinsic and intrinsic effectors, including growth factors and intracellular signaling, can initiate autophagy. Autophagy is involved in diverse physiological events, including survival, differentiation, and development, and contributes to various disorders when it goes awry. So it is of critical importance to maintain appropriate autophagy for the sake of species survival, similar to the elaborated regulation of innate immunity. RNF216/Triad3A (ring finger protein 216)-mediated regulation of innate immunity represents such a mechanism.Identified as a RING finger type E3 ubiquitin (Ub) ligase, RNF216 mediates ligation of Ub to diverse TLR, such as TLR4 and TLR9, leading to protein degradation and negative regulation of TLR signaling. Subsequent studies demonstrate that RNF216 binds toll-interleukin 1 receptor (TIR) domain-containing adaptor proteins, such as RIPK1 (receptor [TNFRSF]-interacting serine-threonine kinase 1), which is critical for downstream TNF (tumor necrosis factor) production. Identification of TRAF3 (TNF receptor-associated factor 3) as a target of RNF216-mediated ubiquitination has revealed RNF216 as an emerging multifunction regulator in innate immunity. Further exploration shows that RNF216 negatively regulates the DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 (DDX58/RIG-I) RNA sensing pathway through lysine 48 (K48)-linked, Ub-mediated degradation of the TRAF3 adaptor.Due to the widespread crosstalk between autophagy and innate immunity, we hypothesized that RNF216 regulates the autophagy process. To our surprise, RNF216 inhibits starvation-induced autophagy besides TLR4-mediated autophagy, suggesting the existence of unknown common mechanism underlying the inhibition of RNF216 on autophagy. Based on the hypothesis, we elucidate the function of RNF216 on autophagy and the novel mechanism. Our data demonstrate that RNF216 interacts with BECN1/Beclin 1 and promotes its ubiquitination, which accelerates the degradation of BECN1, thereby inhibiting autophagy. We further show that this mechanism is involved in pathogen response, as with the model of L. monocytogenesinfection. Thus, our work identifies a novel negative regulator of autophagy that potentially provides a new therapeutic target for infectious and inflammatory diseases.
Results
RNF216 negatively regulates autophagy
Autophagy is a cellular response upon environment stress to maintain homeostasis. Starvation is a classic means to induce autophagy, and lipopolysaccharide (LPS) treatment induces considerable autophagy in immune cells, such as macrophages. We used murine macrophage RAW 264.7 cells to investigate the roles of RNF216 in autophagy. First RAW 264.7 cells were transfected with Flag-Rnf216 and subjected to either serum starvation or LPS. The induction of autophagy is assessed by monitoring MAP1LC3A (microtubule-associated protein 1 light chain 3 α) using immunoblotting. MAP1LC3A is a mammalian ortholog of the autophagy-related gene ATG8 in yeast, and is subject to lipidation with phosphatidylethanolamine upon autophagy induction, thus forming MAP1LC3A-II, which associates with the phagophore and autophagosome membrane. This makes MAP1LC3A-II a common readout for autophagy. As shown in , both starvation (Hank's balanced salt solution treatment) and TLR4 activation (LPS stimulation) significantly increased the level of MAP1LC3A-II in RAW 264.7 cells. However, MAP1LC3A-II formation was inhibited by RNF216 overexpression compared with cells transfected with empty vector (). Next we monitored the autophagy formation using confocal imaging. The RAW 264.7 cells were transfected with an expression vector for green fluorescence protein-fused MAP1LC3A (GFP-MAP1LC3A). Upon autophagy initiation, GFP-MAP1LC3A is recruited from the cytosol to phagophore membranes, which can be visualized as puncta by confocal microscopy. As an evolutionarily conserved homeostasis mechanism, the basal level of autophagy is usually pretty low for cells in a resting state. For RAW 264.7 cells in this study, the puncta structure (autophagy) was observed rarely in physiological condition (empty vector group), and we also saw no considerable change even if RNF216 was overexpressed (). BECN1, the mammalian ortholog of yeastVps30/Atg6, has been commonly regarded as an essential molecule in autophagosome formation, however, there does exist noncanonical autophagy which is independent on BECN1. In order to clarify whether it is canonical or noncanonical autophagy that RNF216 inhibited, we monitored autophagy induction under starvation or LPS stimulation in macrophages, following BECN1 knockdown by small interfering RNA against Becn1 (siBecn1), and our data showed that no autophagosomes were observed in BECN1-knockdown RAW 264.7 cells (), demonstrating the inhibition of canonical autophagy by RNF216. However, upon either starvation or TLR4 activation, the featured puncta increased significantly in empty vector-transfected RAW 264.7 cells, while overexpression of RNF216 prevented the increase considerably ().
Figure 1.
RNF216 inhibits autophagy in macrophages stimulated with LPS. (A and B) RAW 264.7 cells were transfected with Rnf216 vector or empty vector, and then stimulated without or with LPS (100 ng/mL) for 16 h (A) or were on starvation for 4 h (B). Cell lysates were separated with SDS-PAGE and transferred to polyvinylidene difluoride membranes, following with MAP1LC3A antibody and proper HRP-conjugated secondary antibody. EV, empty vector. The band densitometry was quantified using ImageJ software. The quantitative data were calculated from 3 independent experiments, and were shown as mean ± SEM. (C) Cells grown on coverslips were transiently transfected with GFP-MAP1LC3A and either EV, Rnf216, or siBecn1 overnight, followed by treatment with LPS (100 ng/ml) for 16 h or starvation for 4 h, and then fixed. Digital images were captured with confocal microscopy. Scale bar = 10 μm. (D) Cells with featured puncta were considered as autophagy-positive, and at least 100 cells were quantified. Puncta dots per cell were shown as mean ± SEM. (*P < 0.05).
RNF216 inhibits autophagy in macrophages stimulated with LPS. (A and B) RAW 264.7 cells were transfected with Rnf216 vector or empty vector, and then stimulated without or with LPS (100 ng/mL) for 16 h (A) or were on starvation for 4 h (B). Cell lysates were separated with SDS-PAGE and transferred to polyvinylidene difluoride membranes, following with MAP1LC3A antibody and proper HRP-conjugated secondary antibody. EV, empty vector. The band densitometry was quantified using ImageJ software. The quantitative data were calculated from 3 independent experiments, and were shown as mean ± SEM. (C) Cells grown on coverslips were transiently transfected with GFP-MAP1LC3A and either EV, Rnf216, or siBecn1 overnight, followed by treatment with LPS (100 ng/ml) for 16 h or starvation for 4 h, and then fixed. Digital images were captured with confocal microscopy. Scale bar = 10 μm. (D) Cells with featured puncta were considered as autophagy-positive, and at least 100 cells were quantified. Puncta dots per cell were shown as mean ± SEM. (*P < 0.05).To further confirm the influence of RNF216 on the autophagic process, we knocked down RNF216 in RAW 264.7 cells by expressing 2 different short hairpin RNAs (shRNAs) specific for Rnf216 (shRnf1 and 2). The knockdown efficiency by shRNAs was confirmed via immunoblotting of the endogenous protein levels (). RAW 264.7 cells with RNF216 knockdown were serum starved or treated with LPS, and the induction of autophagy was monitored both by the level of MAP1LC3A-II and the number of GFP-MAP1LC3A puncta. Knockdown of RNF216 in RAW 264.7 cells substantially increased the autophagy initiated by starvation or LPS treatment, as measured by either MAP1LC3A II conversion () or by puncta structure formation (). However, this promotion of autophagy by RNF216 deficiency was obviated if combined with knockdown of BECN1 by siBecn1 (). Taken together, our results demonstrate that RNF216 negatively regulates the BECN1-dependent autophagy upon either starvation or TLR4 activation, suggesting a general mechanism for restricting autophagy.
Figure 2.
Knockdown of RNF216 expression abrogates the inhibition of RNF216 on autophagy induction. (A) RAW 264.7 cells were infected with lentivirus with scrambled shRNA (shNC) or Rnf216 shRNA1 and 2 (shRnf1, and 2) (MOI=10), and 48 h later, the cells were lysed and subject to SDS-PAGE followed by being transferred to nitrocellulose membrane. After blotting with RNF216 antibody, the membrane was incubated with HRP-conjugated secondary antibody, and visualized with an ECL chemiluminescence kit. (B and C) RAW 264.7 cells infected with lentivirus with shNC or shRnf2 (MOI=10) were treated with LPS (100 ng/mL) for 16 h (B), or starvation for 4 h (C), then the cells were lysed and subjected to SDS-PAGE followed by being transferred to nitrocellulose membrane. After blotting with MAP1LC3A antibody, the membrane was incubated with HRP-conjugated secondary antibody, and visualized with an ECL chemiluminescence kit. The band densitometry was quantified using ImageJ software. The quantitative data were calculated from 3 independent experiments, and were shown as mean ± SEM. (D) RAW 264.7 cells infected with lentivirus containing scrambled shNC, or shRnf2 (MOI=10) alone or combined with siBecn1 transfection were grown on coverslips, and transiently transfected with GFP-MAP1LC3A overnight, followed by treatment with LPS (100 ng/ml) for 16 h or starvation for 4 h, and then fixed. Digital images were captured with confocal microscopy. Scale bar = 10 μm. (E) Cells with featured puncta were considered as autophagy-positive, and at least 100 cells were quantified. Puncta dots per cell were shown as mean ± SEM. (*P < 0.05).
Knockdown of RNF216expression abrogates the inhibition of RNF216 on autophagy induction. (A) RAW 264.7 cells were infected with lentivirus with scrambled shRNA (shNC) or Rnf216 shRNA1 and 2 (shRnf1, and 2) (MOI=10), and 48 h later, the cells were lysed and subject to SDS-PAGE followed by being transferred to nitrocellulose membrane. After blotting with RNF216 antibody, the membrane was incubated with HRP-conjugated secondary antibody, and visualized with an ECL chemiluminescence kit. (B and C) RAW 264.7 cells infected with lentivirus with shNC or shRnf2 (MOI=10) were treated with LPS (100 ng/mL) for 16 h (B), or starvation for 4 h (C), then the cells were lysed and subjected to SDS-PAGE followed by being transferred to nitrocellulose membrane. After blotting with MAP1LC3A antibody, the membrane was incubated with HRP-conjugated secondary antibody, and visualized with an ECL chemiluminescence kit. The band densitometry was quantified using ImageJ software. The quantitative data were calculated from 3 independent experiments, and were shown as mean ± SEM. (D) RAW 264.7 cells infected with lentivirus containing scrambled shNC, or shRnf2 (MOI=10) alone or combined with siBecn1 transfection were grown on coverslips, and transiently transfected with GFP-MAP1LC3A overnight, followed by treatment with LPS (100 ng/ml) for 16 h or starvation for 4 h, and then fixed. Digital images were captured with confocal microscopy. Scale bar = 10 μm. (E) Cells with featured puncta were considered as autophagy-positive, and at least 100 cells were quantified. Puncta dots per cell were shown as mean ± SEM. (*P < 0.05).
RNF216 promotes proteasomal degradation of BECN1
Previous studies have demonstrated that RNF216 dampens TLR4-mediated signaling by interacting, directly or indirectly, with TLR4, TICAM1, TIRAP, and RIPK1 and stimulating the degradation of these molecules. Because RNF216 negatively regulates autophagy induced through LPS treatment or starvation, we hypothesized that RNF216 interacts with other molecules that are important for autophagy. We constructed various Myc-tagged plasmids containing the sequences of genes that are essential for autophagy, including Atg5, Atg14, and Becn1. After cotransfecting the Flag-Rnf216 and different Myc-tagged molecules (with Tirap as a positive control), we monitored the expression of the molecules, and the results showed that there was no visible change for ATG5 and ATG14, while the expression of BECN1 was markedly decreased (). In order to confirm the effects of degradation of BECN1 by RNF216, we cotransfected Myc-Becn1 and different doses of Flag-Rnf216 into 293T cells and found that BECN1 levels decreased with increased expression of RNF216 (), suggesting that RNF216 downregulates BECN1. During protein turnover, there are 2 pathways involved in protein degradation, utilizing the proteasome and the lysosome. To further investigate the localization of BECN1 degradation, we treated 293T cells with MG132, an irreversible proteasome inhibitor, or E64d, a lysosomal protease inhibitor. Degradation of BECN1 was blocked by MG132 treatment, while E64d treatment did not modify RNF216-mediated degradation of BECN1 (). Collectively, our results demonstrate that RNF216 promotes BECN1 degradation through a proteasome-dependent pathway.
Figure 3.
Inhibition of autophagy by RNF216 was mediated through BECN1. (A) Flag-Rnf216 and Myc-tagged plasmid (Atg5, Atg14, Tirap, Becn1) were used to transfect the 293T cells. Then the cells were lysed and subjected to immunoblotting, and the bands were visualized with an ECL chemiluminescence kit. (B) 293T cells were transfected with Becn1 combined with increased Rnf216, and subjected to immunoblotting for the corresponding proteins. (C) 293T cells transfected with Becn1 and Rnf216 were treated with MG132 or E64d, and lysed before being subjected to SDS-PAGE, followed by transferring to nitrocellulose membrane. Then the membrane was blotted with anti-Flag or -Myc antibody, and then incubated with HRP-conjugated secondary antibody. The bands were visualized with an ECL chemiluminescence kit. The images displayed were representatives from 3 independent experiments.
Inhibition of autophagy by RNF216 was mediated through BECN1. (A) Flag-Rnf216 and Myc-tagged plasmid (Atg5, Atg14, Tirap, Becn1) were used to transfect the 293T cells. Then the cells were lysed and subjected to immunoblotting, and the bands were visualized with an ECL chemiluminescence kit. (B) 293T cells were transfected with Becn1 combined with increased Rnf216, and subjected to immunoblotting for the corresponding proteins. (C) 293T cells transfected with Becn1 and Rnf216 were treated with MG132 or E64d, and lysed before being subjected to SDS-PAGE, followed by transferring to nitrocellulose membrane. Then the membrane was blotted with anti-Flag or -Myc antibody, and then incubated with HRP-conjugated secondary antibody. The bands were visualized with an ECL chemiluminescence kit. The images displayed were representatives from 3 independent experiments.
RNF216 interacts with BECN1 through the triad domain
To further explore the mechanism by which RNF216 degrades BECN1expression, we first investigated the existence of a physical interaction between these proteins. Plasmids Myc-Becn1 and Flag-Rnf216 were cotransfected into 293T cells, and immunoprecipitation experiments were performed with Myc or Flag antibodies. As shown in , RNF216 was coprecipitated with BECN1, and vice versa. To probe for an interaction between endogenous RNF216 and BECN1, RAW 264.7 cells were subject to starvation or LPS stimulation, followed by immunoprecipitation assays with BECN1 or RNF216 antibodies. We observed interactions between BECN1 and RNF216 constitutively, however, autophagy induction initiated stronger binding between these proteins (). We next performed double-immunofluorescence staining of RNF216 and BECN1 to study their colocalization in RAW 264.7 cells grown on coverslips. There was no visible colocalization between these proteins in the basal state, however the colocalization was considerably increased in perinuclear regions after starvation or LPS stimulation ().
Figure 4.
RNF216 interacts with BECN1 through the triad domain. (A) 293T cells transfected with plasmids of Flag-Rnf216 and Myc-Becn1 were immunoprecipitated with IgG, Myc (left panel) or Flag (right panel) antibodies. The precipitates were subjected to blotting with the indicated antibodies, and the bands were visualized with an ECL chemiluminescence kit. (B) RAW 264.7 cells subjected to starvation or LPS treatment were immunoprecipitated with an antibody against RNF216 (left panel) or BECN1 (right panel), followed by immunoblotting with the indicated antibodies, and the bands were visualized with an ECL chemiluminescence kit. The images displayed are representative of 3 independent experiments. The densitometry of the bands was quantified using ImageJ software, and is shown as mean ± SEM. (C) RAW 264.7 cells grown on coverslips were subjected to starvation or LPS (100 ng/mL) treatment, followed by staining with BECN1, RNF216, and DAPI. The images were captured with a confocal microscope. Colocalization of BECN1 and RNF216 was processed using LaserSharp 2000 software (Bio-Rad), is presented as a percentage of RNF216, and is shown as mean ± SEM calculated from 3 independent experiments (*P < 0.05). Scale bar = 10 μm. (D) Schematic diagram of RNF216 and truncation mutants used in this study. TIM, TRAF6 interacting domain; IBR, ‘in-between-RING’ domain. (E) Myc-tagged full-length RNF216 or truncates were transiently transfected into 293T cells. Cell lysates were analyzed by immunoblotting with anti-Myc antibody for the expression of RNF216 protein or by immunoprecipitation with anti-BECN1 antibody following by immunoblotting with the anti-Myc antibody for the association between RNF216 and BECN1 proteins.
RNF216 interacts with BECN1 through the triad domain. (A) 293T cells transfected with plasmids of Flag-Rnf216 and Myc-Becn1 were immunoprecipitated with IgG, Myc (left panel) or Flag (right panel) antibodies. The precipitates were subjected to blotting with the indicated antibodies, and the bands were visualized with an ECL chemiluminescence kit. (B) RAW 264.7 cells subjected to starvation or LPS treatment were immunoprecipitated with an antibody against RNF216 (left panel) or BECN1 (right panel), followed by immunoblotting with the indicated antibodies, and the bands were visualized with an ECL chemiluminescence kit. The images displayed are representative of 3 independent experiments. The densitometry of the bands was quantified using ImageJ software, and is shown as mean ± SEM. (C) RAW 264.7 cells grown on coverslips were subjected to starvation or LPS (100 ng/mL) treatment, followed by staining with BECN1, RNF216, and DAPI. The images were captured with a confocal microscope. Colocalization of BECN1 and RNF216 was processed using LaserSharp 2000 software (Bio-Rad), is presented as a percentage of RNF216, and is shown as mean ± SEM calculated from 3 independent experiments (*P < 0.05). Scale bar = 10 μm. (D) Schematic diagram of RNF216 and truncation mutants used in this study. TIM, TRAF6 interacting domain; IBR, ‘in-between-RING’ domain. (E) Myc-tagged full-length RNF216 or truncates were transiently transfected into 293T cells. Cell lysates were analyzed by immunoblotting with anti-Myc antibody for the expression of RNF216 protein or by immunoprecipitation with anti-BECN1 antibody following by immunoblotting with the anti-Myc antibody for the association between RNF216 and BECN1 proteins.To clarify the binding site between RNF216 and BECN1, we generated truncation mutants of RNF216. As RNF216 contains 2 distinct domains, we created truncations of each domain, as shown in . The first truncation eliminates the TIM domain (RNF216 [1 to 434]), and the other eliminates the triad (2 RING fingers and a DRIL [double RING finger linked]) domain (RNF216 [435 to 866]). The full-length and truncated RNF216 proteins were expressed in 293T cells and analyzed by coimmunoprecipitation and immunoblotting to determine their binding with BECN1. The results showed that triad domain is indispensable for binding to BECN1, while TIM domain is not necessary (). All together, these data demonstrate the physical interaction between RNF216 and BECN1 through the triad domain.
RNF216 promotes K48-linked ubiquitination of BECN1
Before being transported to the proteasome for degradation, proteins usually are subjected to ubiquitination. Thus we tested whether ubiquitination of BECN1 increased during autophagy induction. We stimulated RAW 264.7 cells with LPS, there was slight ubiquitination of BECN1. However, immunoprecipitation using an antibody against RNF216, followed by immunoblotting for BECN1, shows increasing ubiquitination with longer LPS stimulation (), suggesting a specific ubiquitination of BECN1 by RNF216. Treatment of RAW 264.7 cells with a higher concentration of LPS promotes the ubiquitination, while knockdown of RNF216 with specific shRnf2 abolishes the ubiquitination (), implying the potential role of RNF216 in BECN1 ubiquitination. In order to confirm this mechanism, we first assayed in vivo ubiquitination of Myc-tagged BECN1 in 293T cell after transfection with plasmids for RNF216 and HA-Ub. Immunoprecipitated BECN1 had increased levels of polyubiquitination when RNF216 and MG132 were expressed simultaneously compared to BECN1 and Ub alone (). Increasing the transfected amount of RNF216 led to even more readily detectible ubiquitination (, left panel), supporting the essential role of RNF216 in ubiquitination of BECN1. The RING1 domain of triad E3 ligases mediates the interaction with E2 conjugase, and thus plays an indispensible role to position Ub in preparation for its transfer to substrate proteins. So we constructed a RNF216 truncate with a RING1 domain (512 to 567) deletion (RNF216RING1Δ), which lacks the ability of transferring Ub. After cotransfection RAW 264.7 cells with the indicated plasmids, we found that in contrast to wild-type RNF216 transfection, the ubiquitination of BECN1 in the RNF216RING1Δ transfection remained elusive to detect (, right panel), confirming the essential role of RNF216 in BECN1 ubiquitination. We then expressed different mutants of Ub combined with RNF216 and BECN1, and found that RNF216 promoted K48-linked, but not K29 or K63-linked polyubiquitination of BECN1 (). Using suboptimal levels of Flag-tagged RNF216 limited BECN1 ubiquitination (). Lastly, the different Ub mutants were transfected in 293T cells, and the degradation of BECN1 was observed in intact K48 Ub-expressing cells (as in WT, K29R, and K48), but not in K48-mutant cells (), further confirming that the RNF216-mediated modification of BECN1 is a K48-linked ubiquitination. Collectively, these data demonstrate that RNF216-mediated degradation of BECN1 occurs through modification of K48-linked ubiquitination.
Figure 5 (see previous page).
K48 ubiquitination mediated by RNF216 is necessary for BECN1 degradation. (A) RAW 264.7 cells were stimulated with LPS (100 ng/mL) for different periods of time, followed by immunoprecipitation with anti-RNF216 antibody, and then blotted with the indicated antibodies. Meanwhile, lysates were immunoblotted with different antibodies, followed by band visualization. (B) RAW 264.7 cells infected with lentivirus with scrambled shNC or shRnf2 (MOI=10) were treated with or without LPS (at the indicated concentration) for 1 h, followed by immunoprecipitation with anti-RNF216 antibody, and then blotted with the indicated antibodies. Meanwhile, lysates were immunoblotted with different antibodies, followed by band visualization. (C) RAW 264.7 cells transfected with the indicated plasmids were subjected to treatments in the absence or presence of MG-132, and followed by immunoprecipitation with anti-Myc antibody, then blotted with anti-HA antibody. The bands were visualized with an ECL chemiluminescence kit. (D) RAW 264.7 cells transfected with the indicated plasmids (RING1Δ represents Rnf216RING1Δ) were subjected to immunoprecipitation with anti-Myc antibody, then blotted with anti-HA antibody. The bands were visualized with an ECL chemiluminescence kit. (E) Schematic illustration of HA-Ub wild type (WT) and mutants. (F) RAW 264.7 cells transfected with the indicated plasmids were subjected to immunoprecipitation with anti-Myc antibody, then blotted with anti-HA antibody. The bands were visualized with an ECL chemiluminescence kit. (G) RAW 264.7 cells transfected with the indicated plasmids were subjected to immunoblotting with indicated antibodies. The bands were visualized with an ECL chemiluminescence kit. The band densitometries were quantified using ImageJ software. The quantitative data were calculated from 3 independent experiments, and are shown as mean ± SEM. (*P < 0.05).
K48 ubiquitination mediated by RNF216 is necessary for BECN1 degradation. (A) RAW 264.7 cells were stimulated with LPS (100 ng/mL) for different periods of time, followed by immunoprecipitation with anti-RNF216 antibody, and then blotted with the indicated antibodies. Meanwhile, lysates were immunoblotted with different antibodies, followed by band visualization. (B) RAW 264.7 cells infected with lentivirus with scrambled shNC or shRnf2 (MOI=10) were treated with or without LPS (at the indicated concentration) for 1 h, followed by immunoprecipitation with anti-RNF216 antibody, and then blotted with the indicated antibodies. Meanwhile, lysates were immunoblotted with different antibodies, followed by band visualization. (C) RAW 264.7 cells transfected with the indicated plasmids were subjected to treatments in the absence or presence of MG-132, and followed by immunoprecipitation with anti-Myc antibody, then blotted with anti-HA antibody. The bands were visualized with an ECL chemiluminescence kit. (D) RAW 264.7 cells transfected with the indicated plasmids (RING1Δ represents Rnf216RING1Δ) were subjected to immunoprecipitation with anti-Myc antibody, then blotted with anti-HA antibody. The bands were visualized with an ECL chemiluminescence kit. (E) Schematic illustration of HA-Ub wild type (WT) and mutants. (F) RAW 264.7 cells transfected with the indicated plasmids were subjected to immunoprecipitation with anti-Myc antibody, then blotted with anti-HA antibody. The bands were visualized with an ECL chemiluminescence kit. (G) RAW 264.7 cells transfected with the indicated plasmids were subjected to immunoblotting with indicated antibodies. The bands were visualized with an ECL chemiluminescence kit. The band densitometries were quantified using ImageJ software. The quantitative data were calculated from 3 independent experiments, and are shown as mean ± SEM. (*P < 0.05).
RNF216 regulates TLR-mediated antimicrobial responses via control of autophagy
Autophagy has been proposed to be a mechanism of innate immunity against various intracellular pathogens, such as L. monocytogenes, especially in the early phase of infection. We further investigated the function of RNF216 in controlling TLR-mediated uptake of bacteria into autophagosomes and restriction of their growth. We inoculated mice intratracheally (i.t.) with the gram-negative bacteria, L. monocytogenes, which invades alveolar macrophages and rarely lung epithelial cells. Before the infection of L. monocytogenes, some of mice were inoculated i.t. with lentivirus containing Rnf216 (overexpression) or shRnf2 (knockdown). After 48 h, alveolar macrophages were isolated from the mice. Immunoblot analysis demonstrates that RNF216 was successfully overexpressed or knocked down (). Induction of autophagy was assessed by MAP1LC3A-II immunoblotting. L. monocytogenesinfection strongly promoted autophagy in alveolar macrophages, and RNF216 overexpression dampens this response drastically (, left panel). Knockdown of RNF216 had the opposite effect, suggesting a role for RNF216 in autophagy. Accordingly, the growth of L. monocytogenes was much higher when RNF216 was overexpressed, while RNF216 knockdown inhibited proliferation of the bacteria (). Infection of bone marrow-derived macrophages (BMDM) with L. monocytogenes in vitro induces autophagy, and modification of RNF216expression in BMDM produce similar effects on autophagy to alveolar macrophages (, right panel), emphasizing the crucial role of RNF216 in regulation of L. monocytogenes-induced autophagy. Likewise, the recovered bacteria from BMDM with RNF216 overexpression showed stronger growth, in contrast to RNF216 knockdown (), showing the vital part of RNF216 in host response to L. monocytogenesinfection. Bronchoalveolar lavage fluid (BALF) was collected from mice with L. monocytogenesinfection, and the levels of inflammatory cytokines such as TNF and IL6. TNF and IL6 were assayed, which were significantly higher when RNF216 was overexpressed, and much lower when RNF216 was knocked down (). These data support the idea that RNF216 can control the progression of infections. Together, our results demonstrate the essential role of RNF216 in TLR-mediated antimicrobial responses through control of autophagy.
Figure 6.
Inhibition of RNF216 contributes to elimination of intracellular pathogens. Mice were infected with lentivirus i.t., followed by infection with Listeria monocytogenes i.t.. Twenty-four h later, the mice were sacrificed. The alveolar macrophages were isolated and lysed, then subjected to immunoblotting with RNF216 antibody (A) or MAP1LC3A antibody (B, left panel). BMDM with the indicated treatment also were lysed and immunobloted to detect MAP1LC3A expression (B, right panel). The band densitometries were quantified using ImageJ software. Meanwhile Listeria monocytogenes used for infection and recovered from alveolar macrophages (C) or BMDM (D) were cultured, then the CFU was calculated, and the percentage represents the ratio of CFU of recovered bacterial with that of the bacteria used for infection (C, D). (E) BALF was prepared, and ELISA was used to detect the inflammatory cytokines IL6 and TNF. All quantified data were calculated from 3 independent experiments, and presented as mean ± SEM. (*P < 0.05).
Inhibition of RNF216 contributes to elimination of intracellular pathogens. Mice were infected with lentivirus i.t., followed by infection with Listeria monocytogenes i.t.. Twenty-four h later, the mice were sacrificed. The alveolar macrophages were isolated and lysed, then subjected to immunoblotting with RNF216 antibody (A) or MAP1LC3A antibody (B, left panel). BMDM with the indicated treatment also were lysed and immunobloted to detect MAP1LC3Aexpression (B, right panel). The band densitometries were quantified using ImageJ software. Meanwhile Listeria monocytogenes used for infection and recovered from alveolar macrophages (C) or BMDM (D) were cultured, then the CFU was calculated, and the percentage represents the ratio of CFU of recovered bacterial with that of the bacteria used for infection (C, D). (E) BALF was prepared, and ELISA was used to detect the inflammatory cytokines IL6 and TNF. All quantified data were calculated from 3 independent experiments, and presented as mean ± SEM. (*P < 0.05).
Discussion
A myriad of biological stimuli and environment stresses contribute to autophagy, an ancient biological process for maintaining cellular homeostasis. Following induction, autophagy will go through steps of phagophore elongation, and maturation into an autophagosome, which subsequently fuses with a lysosome where the cargoes are delivered for degradation and recycling. During the process, numerous homologs and orthologs of products of autophagy-related genes have been identified, that signal to the autophagic machinery. Among them, BECN1 is arguably the most-studied molecule regulating the process, and is central to health and disease processes such as tumor, inflammation, and aging. BECN1 is one of the key initiators of the autophagic process, which associates with PtdIns3K, thereby mediating biogenesis and dynamics of subcellular membranes involved in autophagy.Due to its multiple functions and diverse roles in cellular survival and death, it is no surprise that there are many mechanisms regulating BECN1. It has been reported that binding partners of BECN1, such as the autophagy/Beclin 1 regulator 1 (AMBRA1), UV radiation resistance associated (UVRAG), and ATG14/Barkor positively regulate autophagy, whereas B-cell CLL/lymphoma 2 (BCL2) and KIAA0226/Rubicon (1700021K19Rik in mice) inhibit autophagy. Furthermore, a recent study demonstrated that K63-linked ubiquitination of BECN1 is regulated by TRAF6 and tumor necrosis factor α-induced protein 3 (TNFAIP3/A20). TRAF6 promotes the K63-linked ubiquitination of BECN1 to induce TLR4-mediated autophagy, and tumor necrosis factor α-induced protein 3 deubiquitinates the K63-linked Ub chains. However, we found in previous studies that BECN1 experienced K48-linked ubiquitination, the E3 Ub-protein ligase mediated the modification remains to be identified. In addition, the function of K48-linked ubiquitination of BECN1 is also unknown. In this study, we identified RNF216 as an E3 Ub ligase to mediate the K48-linked ubiquitination of BECN1, which represents a negative pathway for autophagy regulation.RNF216 is known to mediate the ubiquitination of various TLRs (TLR4 and TLR9) and downstream signaling molecules, including RIPK1 and TICAM1, causing their subsequent degradation via the proteasome and dampening of NFKB signaling. In addition, RNF216 interacts with TRAF3, induces ubiquitination and degradation of TRAF3 and negatively regulates DEAD (Asp-Glu-Ala-Asp) box polypeptide 58/ mitochondrial antiviral signaling protein (MAVS)-mediated NFKB activation, thereby modulating innate immune receptor responses toward several invading pathogens. It is no wonder that RNF216 interferes with the TLR4-induced autophagy in macrophages. However, when we tried to test whether RNF216 has regulatory effects in autophagy induced by starvation, we observed that RNF216 still has strong inhibition ability on autophagy, which prompted us to focus on common molecules other than those of TLR signaling cascade, such as BECN1 or ATG5 (data not shown). For macrophages in resting state, we observed elusive interaction between RNF216 and BECN1, and there was no considerable inhibition on autophagy by RNF216 overexpression, putatively due to the low basal level of autophagy.Our study further demonstrates that RNF216 physically interacted with BECN1 for macrophages under starvation or treated with LPS. Unlike the interaction between RNF216 and TRAF3 through TIM domain, RNF216 binds to BECN1 through a triad domain consisting of 2 RING domains and an ‘in-between-RING’ domain. The detailed mechanism by which RNF216 ubiquitinates the protein with different domains remains to be elucidated.We sought to evaluate the in vivo function of RNF216 on controlling pathogen growth. L. monocytogenes has been widely used as a model to investigate the pathogenesis of an intracellular microorganisms and the regulation of cellular immunity. When the mice are infected i.t. with L. monocytogenes, most pathogens invade alveolar macrophages.
L. monocytogenesinfection of macrophages induces strong autophagic response, theoretically triggered by activation of TLRs that inhibit the growth of the bacteria and cell-to-cell spreading. In this study, we found that overexpression of RNF216 in alveolar macrophages inhibited autophagy, which contributed to L. monocytogenes growth and spread, while knockdown of RNF216 had the opposite effects. Accordingly, the pulmonary inflammation in mice with RNF216 overexpression was much more severe than that without RNF216 overexpression, while that in mice with RNF216 knockdown was much less severe.In summary, we found RNF216 could potently downregulate autophagy through promoting proteasome-dependent degradation of BECN1 via K48-linked ubiquitination. Given the importance of autophagy in the innate immune responses during bacterial and viral infection, our study identifies a novel regulator of autophagy and represents a potential target for drug development in the control of various diseases such as infectious disease, where autophagy has gone awry.
Materials and Methods
Reagents and antibodies
LPS (Re595) from Salmonella minnesota R595, MG132 and E64d were purchased from Sigma (L9764, M7449, and E8640). Anti-Myc, anti-Flag, anti-HA, anti-MAP1LC3A monoclonal antibodies (mAbs) were purchased from Cell Signaling Technology (2287, 8146, 2367, and 12741). Ub K48-specific mAb and Ub K63-specific mAb were purchased from Millipore (05–1307, 05–1313). BECN1 mAb was purchased from Santa Cruz Biotechnology (sc-49341). Rabbit polyclonal anti-RNF216 Ab was from Abcam (ab25961). HRP-conjugated anti-mouse and anti-rabbit secondary antibodies were purchased from Jackson ImmunoResearch (115–035–003, 111–035–003). siBecn1 targeting mouseBecn1 was obtained from Life Technologies (s80168).
cDNA and plasmid constructs
The GFP-MAP1LC3A construct was a kind gift from Dr. Tamotsu Yoshimori (Osaka University, Osaka, Japan). HA-Ub wild-type, knockout, K29, K29R, K48, K63 and K48R Ub mutants were from Addgene (Plasmid # 17608, 17603, 22903, 17602, 17605, 17606, 17604, respectively). Full-length Becn1, Bcl2 and Rnf216 cDNAs were PCR amplified from first-strand cDNA libraries, as described previously. cDNAs for Rnf216 truncations were generated by PCR amplification with the full-length Rnf216 cDNA as template. These cDNAs were subcloned into PRK5 mammalianexpression vectors containing an N-terminal Myc or Flag epitope tag. The cDNA of mouse Flag-Rnf216 in a pRK5 vector was also cloned into pLVX-IRES-EGFP. Rnf216 shRNA1 (shRnf1) targeting nucleotide sequence (1532 to 1551) 5′-GAGCAGGAGTTCTATGAGCA-3′, Rnf216 shRNA2 (shRnf2) targeting nucleotide sequence (1195 to 1214) 5′-GGACACTATGCAATCACCCG-3′ and scrambled shRNA control (shNC) have been previously described.
Cell culture and transfection
RAW 264.7 cells and 293T cells were cultured in DMEM medium supplemented with 10% FBS. 293T cells were transfected by using Lipofectamine 2000 (Invitrogen, 11668019). BMDM were obtained as previously described with modification. Briefly, cells were prepared by flushing the bone marrow from femurs and tibias and then maintained in DMEM medium containing 10% FBS and supplemented with 10 ng/ml M-CSF (Peprotech, 315–02). Four to 5 d later, adherent cells were dissociated and cultured in DMEM supplemented with 10% FBS and growth factor. RAW 264.7 and BMDM cells were transfected with TransIT-Jurkat (Mirus Bio, MIR2125), according to the manufacturer's instruction.
Immunoblotting
Cell lysates were subjected to SDS-PAGE and transferred to polyvinylidene difluoride membranes. The membranes were blocked with 5% fat-free milk in phosphate-buffered saline (PBS, Gibco, 21600–044) with 0.1% Tween-20 (Sinopharm Chemicals, 30189328) for 2 h and then incubated with the indicated antibody in PBS plus 0.5% fat-free milk overnight. After washing, the membranes were incubated with HRP-conjugated goat anti-mouse or anti-rabbit IgG (Jackson ImmunoResearch Laboratories, 115–035–003, 111–035–003) for 1 h. After subsequent washes, the immunoreactive bands were visualized with ECL Plus Western blotting detection reagents (Millipore, 2650). For some immunoblots, the band densitometry was quantified using ImageJ software (National Institutes of Health).
Coimmunoprecipitation
Cells were lysed in lysis buffer [50 mM Tris-HCl, pH 7.4, 250 mM NaCl, 0.5% Nonidet P-40 (Sangon Biotech, NE109), plus complete protease inhibitor mixture (Roche Applied Science, 04693116001)]. Cell lysates were clarified by centrifugation and incubated with the indicated antibody plus protein G-Sepharose (Amersham Biosciences, 17–0618–02) at 4°C overnight to form immunocomplexes. After extensive washing with lysis buffer, the immunocomplexes were analyzed by immunoblotting as described.
Fluorescence confocal microscopy
Cells grown on coverslips were fixed in BD Cytofix/Cytoperm solution (BD Biosciences, 554714) at room temperature for 15 min. These coverslips were incubated with the primary antibody, followed by fluorochrome-conjugated secondary antibody, before mounting. For fluorescence analysis, cell samples were visualized on an Olympus Fluoview confocal microscope with appropriate emission filters (Olympus, Tokyo, Japan).
Autophagy analyses
Autophagy was analyzed by immunoblotting or fluorescence microscopy, as described previously. In the immunoblotting analysis, cells were treated as indicated, and cell lysates were immunoblotted with anti-MAP1LC3A antibody to monitor the MAP1LC3A-II generated during the formation of autophagosomes. In the fluorescence confocal microscopy analysis, cells were transfected with a GFP-MAP1LC3A construct and treated as indicated. These cells were imaged by fluorescence confocal microscopy, with single-line excitation at 488 nm for GFP, for the formation of puncta in autophagic cells. A minimum of 100 cells was analyzed for each treatment, and each experiment was performed at least 3 independent times.
Ubiquitination assay
For analysis of ubiquitination of endogenous BECN1, whole-cell extracts were immunoprecipitated with anti-BECN1 and analyzed by western blot with anti-Ub Ab. For analysis of the ubiquitination of overexpressed BECN1, 293T cells were transfected with Myc-Becn1, HA-Ub wild type, or HA-Ub mutants and Flag-Rnf216; then whole-cell extracts were immunoprecipitated with anti-Myc and analyzed by immunoblotting with anti-Ub Ab.
Intratracheal administration of lentivirus
Lentivirus suspensions (100 μl) with a dosage of 5 × 108 plaque-forming units was injected i.t. into mouse lungs, using a Hamilton syringe with a sterile 30-gauge needle. Three d later, mice were used for bacterial infection. Female C57BL/6 mice (8 to 12 wk) used in this study were purchased from the Shanghai Laboratory Animal Center of the Chinese Academy of Sciences, and were kept under specific pathogen-free conditions in the animal center of Shanghai Jiao Tong University School of Medicine (Shanghai, China). All mouse experiments were approved by the Animal Welfare & Ethics Committee of the Shanghai Jiao Tong University School of Medicine.
L. monocytogenes infection
L. monocytogenes used in this study is strain 10403S. Before using for infection, the bacteria were grown in Brain Heart Infusion (BD Biosciences, 237400) broth for 16 h or until mid-log phase growth was reached with shaking. After pellet with centrifugation at 5000 g for 15 min and washing with PBS twice, the bacteria density was determined by spectrophotometry at 600 nm, and diluted with sterile PBS to prepare the inoculum for the mice. For in vivo infection, 1 ×103 (50 μl) bacteria in PBS was used to inoculate the mice i.t.. Twenty-four h later, the mice were sacrificed, and the lungs were removed from the mice. After homogenization, the homogenates were cultured in Brain Heart Infusion agar plates (BD Biosciences, 237400), and bacterial colony forming units (CFU) were determined after 16 h growth at 37°C. For infection of cells, L. monocytogenes were used to infect cells at a multiplicity of infection (MOI) of 2:1. After 1 h after infection, the cells were washed with PBS to remove extracellular bacteria. The cells were cultured in fresh medium for 12 h more, and then washed 3 times with PBS and treated with 0.1% Triton X-100 (Sigma-Aldrich, X100) to harvest the surviving intracellular bacteria. We grew in parallel the original and the recovered bacteria on plates, and the percentage represents the ratio of CFU of recovered bacteria relative to the CFU of the original bacteria used for infection.
BALF collection and isolation of alveolar macrophages
After 2 d of bacterial infection, BALF was collected as previously described. Briefly, the mice were euthanized and the lungs were lavaged with 0.5 ml sterile PBS for 4 times, and the lavage fluid was centrifuged, followed by collection for detection of cytokines or stored at −80°C until use. After suspending the pellet with PBS, the cells were counted and subjected to alveolar macrophages isolation as described.
Statistical analysis
The 2-tailed Student t test or one-way analysis of variance followed by the Turkey post-hoc test was used for all statistical analyses in this study using SPSS 18.0. A P value less than 0.05 is considered as statistically significant.
Authors: Antje Munder; Andrea Zelmer; Andreas Schmiedl; Kurt E J Dittmar; Manfred Rohde; Martina Dorsch; Klaus Otto; Hans-J Hedrich; Burkhard Tümmler; Siegfried Weiss; Thomas Tschernig Journal: Microbes Infect Date: 2005-03-16 Impact factor: 2.700
Authors: Robert J Heath; Gautam Goel; Leigh A Baxt; Jason S Rush; Vishnu Mohanan; Geraldine L C Paulus; Vijay Jani; Kara G Lassen; Ramnik J Xavier Journal: Cell Rep Date: 2016-11-22 Impact factor: 9.423
Authors: John Evankovich; Travis Lear; Courtney Baldwin; Yanwen Chen; Virginia White; John Villandre; James Londino; Yuan Liu; Bryan McVerry; Georgios D Kitsios; Rama K Mallampalli; Bill B Chen Journal: Am J Respir Cell Mol Biol Date: 2020-02 Impact factor: 6.914
Authors: Daniel J Klionsky; Kotb Abdelmohsen; Akihisa Abe; Md Joynal Abedin; Hagai Abeliovich; Abraham Acevedo Arozena; Hiroaki Adachi; Christopher M Adams; Peter D Adams; Khosrow Adeli; Peter J Adhihetty; Sharon G Adler; Galila Agam; Rajesh Agarwal; Manish K Aghi; Maria Agnello; Patrizia Agostinis; Patricia V Aguilar; Julio Aguirre-Ghiso; Edoardo M Airoldi; Slimane Ait-Si-Ali; Takahiko Akematsu; Emmanuel T Akporiaye; Mohamed Al-Rubeai; Guillermo M Albaiceta; Chris Albanese; Diego Albani; Matthew L Albert; Jesus Aldudo; Hana Algül; Mehrdad Alirezaei; Iraide Alloza; Alexandru Almasan; Maylin Almonte-Beceril; Emad S Alnemri; Covadonga Alonso; Nihal Altan-Bonnet; Dario C Altieri; Silvia Alvarez; Lydia Alvarez-Erviti; Sandro Alves; Giuseppina Amadoro; Atsuo Amano; Consuelo Amantini; Santiago Ambrosio; Ivano Amelio; Amal O Amer; Mohamed Amessou; Angelika Amon; Zhenyi An; Frank A Anania; Stig U Andersen; Usha P Andley; Catherine K Andreadi; Nathalie Andrieu-Abadie; Alberto Anel; David K Ann; Shailendra Anoopkumar-Dukie; Manuela Antonioli; Hiroshi Aoki; Nadezda Apostolova; Saveria Aquila; Katia Aquilano; Koichi Araki; Eli Arama; Agustin Aranda; Jun Araya; Alexandre Arcaro; Esperanza Arias; Hirokazu Arimoto; Aileen R Ariosa; Jane L Armstrong; Thierry Arnould; Ivica Arsov; Katsuhiko Asanuma; Valerie Askanas; Eric Asselin; Ryuichiro Atarashi; Sally S Atherton; Julie D Atkin; Laura D Attardi; Patrick Auberger; Georg Auburger; Laure Aurelian; Riccardo Autelli; Laura Avagliano; Maria Laura Avantaggiati; Limor Avrahami; Suresh Awale; Neelam Azad; Tiziana Bachetti; Jonathan M Backer; Dong-Hun Bae; Jae-Sung Bae; Ok-Nam Bae; Soo Han Bae; Eric H Baehrecke; Seung-Hoon Baek; Stephen Baghdiguian; Agnieszka Bagniewska-Zadworna; Hua Bai; Jie Bai; Xue-Yuan Bai; Yannick Bailly; Kithiganahalli Narayanaswamy Balaji; Walter Balduini; Andrea Ballabio; Rena Balzan; Rajkumar Banerjee; Gábor Bánhegyi; Haijun Bao; Benoit Barbeau; Maria D Barrachina; Esther Barreiro; Bonnie Bartel; Alberto Bartolomé; Diane C Bassham; Maria Teresa Bassi; Robert C Bast; Alakananda Basu; Maria Teresa Batista; Henri Batoko; Maurizio Battino; Kyle Bauckman; Bradley L Baumgarner; K Ulrich Bayer; Rupert Beale; Jean-François Beaulieu; George R Beck; Christoph Becker; J David Beckham; Pierre-André Bédard; Patrick J Bednarski; Thomas J Begley; Christian Behl; Christian Behrends; Georg Mn Behrens; Kevin E Behrns; Eloy Bejarano; Amine Belaid; Francesca Belleudi; Giovanni Bénard; Guy Berchem; Daniele Bergamaschi; Matteo Bergami; Ben Berkhout; Laura Berliocchi; Amélie Bernard; Monique Bernard; Francesca Bernassola; Anne Bertolotti; Amanda S Bess; Sébastien Besteiro; Saverio Bettuzzi; Savita Bhalla; Shalmoli Bhattacharyya; Sujit K Bhutia; Caroline Biagosch; Michele Wolfe Bianchi; Martine Biard-Piechaczyk; Viktor Billes; Claudia Bincoletto; Baris Bingol; Sara W Bird; Marc Bitoun; Ivana Bjedov; Craig Blackstone; Lionel Blanc; Guillermo A Blanco; Heidi Kiil Blomhoff; Emilio Boada-Romero; Stefan Böckler; Marianne Boes; Kathleen Boesze-Battaglia; Lawrence H Boise; Alessandra Bolino; Andrea Boman; Paolo Bonaldo; Matteo Bordi; Jürgen Bosch; Luis M Botana; Joelle Botti; German Bou; Marina Bouché; Marion Bouchecareilh; Marie-Josée Boucher; Michael E Boulton; Sebastien G Bouret; Patricia Boya; Michaël Boyer-Guittaut; Peter V Bozhkov; Nathan Brady; Vania Mm Braga; Claudio Brancolini; Gerhard H Braus; José M Bravo-San Pedro; Lisa A Brennan; Emery H Bresnick; Patrick Brest; Dave Bridges; Marie-Agnès Bringer; Marisa Brini; Glauber C Brito; Bertha Brodin; Paul S Brookes; Eric J Brown; Karen Brown; Hal E Broxmeyer; Alain Bruhat; Patricia Chakur Brum; John H Brumell; Nicola Brunetti-Pierri; Robert J Bryson-Richardson; Shilpa Buch; Alastair M Buchan; Hikmet Budak; Dmitry V Bulavin; Scott J Bultman; Geert Bultynck; Vladimir Bumbasirevic; Yan Burelle; Robert E Burke; Margit Burmeister; Peter Bütikofer; Laura Caberlotto; Ken Cadwell; Monika Cahova; Dongsheng Cai; Jingjing Cai; Qian Cai; Sara Calatayud; Nadine Camougrand; Michelangelo Campanella; Grant R Campbell; Matthew Campbell; Silvia Campello; Robin Candau; Isabella Caniggia; Lavinia Cantoni; Lizhi Cao; Allan B Caplan; Michele Caraglia; Claudio Cardinali; Sandra Morais Cardoso; Jennifer S Carew; Laura A Carleton; Cathleen R Carlin; Silvia Carloni; Sven R Carlsson; Didac Carmona-Gutierrez; Leticia Am Carneiro; Oliana Carnevali; Serena Carra; Alice Carrier; Bernadette Carroll; Caty Casas; Josefina Casas; Giuliana Cassinelli; Perrine Castets; Susana Castro-Obregon; Gabriella Cavallini; Isabella Ceccherini; Francesco Cecconi; Arthur I Cederbaum; Valentín Ceña; Simone Cenci; Claudia Cerella; Davide Cervia; Silvia Cetrullo; Hassan Chaachouay; Han-Jung Chae; Andrei S Chagin; Chee-Yin Chai; Gopal Chakrabarti; Georgios Chamilos; Edmond Yw Chan; Matthew Tv Chan; Dhyan Chandra; Pallavi Chandra; Chih-Peng Chang; Raymond Chuen-Chung Chang; Ta Yuan Chang; John C Chatham; Saurabh Chatterjee; Santosh Chauhan; Yongsheng Che; Michael E Cheetham; Rajkumar Cheluvappa; Chun-Jung Chen; Gang Chen; Guang-Chao Chen; Guoqiang Chen; Hongzhuan Chen; Jeff W Chen; Jian-Kang Chen; Min Chen; Mingzhou Chen; Peiwen Chen; Qi Chen; Quan Chen; Shang-Der Chen; Si Chen; Steve S-L Chen; Wei Chen; Wei-Jung Chen; Wen Qiang Chen; Wenli Chen; Xiangmei Chen; Yau-Hung Chen; Ye-Guang Chen; Yin Chen; Yingyu Chen; Yongshun Chen; Yu-Jen Chen; Yue-Qin Chen; Yujie Chen; Zhen Chen; Zhong Chen; Alan Cheng; Christopher Hk Cheng; Hua Cheng; Heesun Cheong; Sara Cherry; Jason Chesney; Chun Hei Antonio Cheung; Eric Chevet; Hsiang Cheng Chi; Sung-Gil Chi; Fulvio Chiacchiera; Hui-Ling Chiang; Roberto Chiarelli; Mario Chiariello; Marcello Chieppa; Lih-Shen Chin; Mario Chiong; Gigi Nc Chiu; Dong-Hyung Cho; Ssang-Goo Cho; William C Cho; Yong-Yeon Cho; Young-Seok Cho; Augustine Mk Choi; Eui-Ju Choi; Eun-Kyoung Choi; Jayoung Choi; Mary E Choi; Seung-Il Choi; Tsui-Fen Chou; Salem Chouaib; Divaker Choubey; Vinay Choubey; Kuan-Chih Chow; Kamal Chowdhury; Charleen T Chu; Tsung-Hsien Chuang; Taehoon Chun; Hyewon Chung; Taijoon Chung; Yuen-Li Chung; Yong-Joon Chwae; Valentina Cianfanelli; Roberto Ciarcia; Iwona A Ciechomska; Maria Rosa Ciriolo; Mara Cirone; Sofie Claerhout; Michael J Clague; Joan Clària; Peter Gh Clarke; Robert Clarke; Emilio Clementi; Cédric Cleyrat; Miriam Cnop; Eliana M Coccia; Tiziana Cocco; Patrice Codogno; Jörn Coers; Ezra Ew Cohen; David Colecchia; Luisa Coletto; Núria S Coll; Emma Colucci-Guyon; Sergio Comincini; Maria Condello; Katherine L Cook; Graham H Coombs; Cynthia D Cooper; J Mark Cooper; Isabelle Coppens; Maria Tiziana Corasaniti; Marco Corazzari; Ramon Corbalan; Elisabeth Corcelle-Termeau; Mario D Cordero; Cristina Corral-Ramos; Olga Corti; Andrea Cossarizza; Paola Costelli; Safia Costes; Susan L Cotman; Ana Coto-Montes; Sandra Cottet; Eduardo Couve; Lori R Covey; L Ashley Cowart; Jeffery S Cox; Fraser P Coxon; Carolyn B Coyne; Mark S Cragg; Rolf J Craven; Tiziana Crepaldi; Jose L Crespo; Alfredo Criollo; Valeria Crippa; Maria Teresa Cruz; Ana Maria Cuervo; Jose M Cuezva; Taixing Cui; Pedro R Cutillas; Mark J Czaja; Maria F Czyzyk-Krzeska; Ruben K Dagda; Uta Dahmen; Chunsun Dai; Wenjie Dai; Yun Dai; Kevin N Dalby; Luisa Dalla Valle; Guillaume Dalmasso; Marcello D'Amelio; Markus Damme; Arlette Darfeuille-Michaud; Catherine Dargemont; Victor M Darley-Usmar; Srinivasan Dasarathy; Biplab Dasgupta; Srikanta Dash; Crispin R Dass; Hazel Marie Davey; Lester M Davids; David Dávila; Roger J Davis; Ted M Dawson; Valina L Dawson; Paula Daza; Jackie de Belleroche; Paul de Figueiredo; Regina Celia Bressan Queiroz de Figueiredo; José de la Fuente; Luisa De Martino; Antonella De Matteis; Guido Ry De Meyer; Angelo De Milito; Mauro De Santi; Wanderley de Souza; Vincenzo De Tata; Daniela De Zio; Jayanta Debnath; Reinhard Dechant; Jean-Paul Decuypere; Shane Deegan; Benjamin Dehay; Barbara Del Bello; Dominic P Del Re; Régis Delage-Mourroux; Lea Md Delbridge; Louise Deldicque; Elizabeth Delorme-Axford; Yizhen Deng; Joern Dengjel; Melanie Denizot; Paul Dent; Channing J Der; Vojo Deretic; Benoît Derrien; Eric Deutsch; Timothy P Devarenne; Rodney J Devenish; Sabrina Di Bartolomeo; Nicola Di Daniele; Fabio Di Domenico; Alessia Di Nardo; Simone Di Paola; Antonio Di Pietro; Livia Di Renzo; Aaron DiAntonio; Guillermo Díaz-Araya; Ines Díaz-Laviada; Maria T Diaz-Meco; Javier Diaz-Nido; Chad A Dickey; Robert C Dickson; Marc Diederich; Paul Digard; Ivan Dikic; Savithrama P Dinesh-Kumar; Chan Ding; Wen-Xing Ding; Zufeng Ding; Luciana Dini; Jörg Hw Distler; Abhinav Diwan; Mojgan Djavaheri-Mergny; Kostyantyn Dmytruk; Renwick Cj Dobson; Volker Doetsch; Karol Dokladny; Svetlana Dokudovskaya; Massimo Donadelli; X Charlie Dong; Xiaonan Dong; Zheng Dong; Terrence M Donohue; Kelly S Doran; Gabriella D'Orazi; Gerald W Dorn; Victor Dosenko; Sami Dridi; Liat Drucker; Jie Du; Li-Lin Du; Lihuan Du; André du Toit; Priyamvada Dua; Lei Duan; Pu Duann; Vikash Kumar Dubey; Michael R Duchen; Michel A Duchosal; Helene Duez; Isabelle Dugail; Verónica I Dumit; Mara C Duncan; Elaine A Dunlop; William A Dunn; Nicolas Dupont; Luc Dupuis; Raúl V Durán; Thomas M Durcan; Stéphane Duvezin-Caubet; Umamaheswar Duvvuri; Vinay Eapen; Darius Ebrahimi-Fakhari; Arnaud Echard; Leopold Eckhart; Charles L Edelstein; Aimee L Edinger; Ludwig Eichinger; Tobias Eisenberg; Avital Eisenberg-Lerner; N Tony Eissa; Wafik S El-Deiry; Victoria El-Khoury; Zvulun Elazar; Hagit Eldar-Finkelman; Chris Jh Elliott; Enzo Emanuele; Urban Emmenegger; Nikolai Engedal; Anna-Mart Engelbrecht; Simone Engelender; Jorrit M Enserink; Ralf Erdmann; Jekaterina Erenpreisa; Rajaraman Eri; Jason L Eriksen; Andreja Erman; Ricardo Escalante; Eeva-Liisa Eskelinen; Lucile Espert; Lorena Esteban-Martínez; Thomas J Evans; Mario Fabri; Gemma Fabrias; Cinzia Fabrizi; Antonio Facchiano; Nils J Færgeman; Alberto Faggioni; W Douglas Fairlie; Chunhai Fan; Daping Fan; Jie Fan; Shengyun Fang; Manolis Fanto; Alessandro Fanzani; Thomas Farkas; Mathias Faure; Francois B Favier; Howard Fearnhead; Massimo Federici; Erkang Fei; Tania C Felizardo; Hua Feng; Yibin Feng; Yuchen Feng; Thomas A Ferguson; Álvaro F Fernández; Maite G Fernandez-Barrena; Jose C Fernandez-Checa; Arsenio Fernández-López; Martin E Fernandez-Zapico; Olivier Feron; Elisabetta Ferraro; Carmen Veríssima Ferreira-Halder; Laszlo Fesus; Ralph Feuer; Fabienne C Fiesel; Eduardo C Filippi-Chiela; Giuseppe Filomeni; Gian Maria Fimia; John H Fingert; Steven Finkbeiner; Toren Finkel; Filomena Fiorito; Paul B Fisher; Marc Flajolet; Flavio Flamigni; Oliver Florey; Salvatore Florio; R Andres Floto; Marco Folini; Carlo Follo; Edward A Fon; Francesco Fornai; Franco Fortunato; Alessandro Fraldi; Rodrigo Franco; Arnaud Francois; Aurélie François; Lisa B Frankel; Iain Dc Fraser; Norbert Frey; Damien G Freyssenet; Christian Frezza; Scott L Friedman; Daniel E Frigo; Dongxu Fu; José M Fuentes; Juan Fueyo; Yoshio Fujitani; Yuuki Fujiwara; Mikihiro Fujiya; Mitsunori Fukuda; Simone Fulda; Carmela Fusco; Bozena Gabryel; Matthias Gaestel; Philippe Gailly; Malgorzata Gajewska; Sehamuddin Galadari; Gad Galili; Inmaculada Galindo; Maria F Galindo; Giovanna Galliciotti; Lorenzo Galluzzi; Luca Galluzzi; Vincent Galy; Noor Gammoh; Sam Gandy; Anand K Ganesan; Swamynathan Ganesan; Ian G Ganley; Monique Gannagé; Fen-Biao Gao; Feng Gao; Jian-Xin Gao; Lorena García Nannig; Eleonora García Véscovi; Marina Garcia-Macía; Carmen Garcia-Ruiz; Abhishek D Garg; Pramod Kumar Garg; Ricardo Gargini; Nils Christian Gassen; Damián Gatica; Evelina Gatti; Julie Gavard; Evripidis Gavathiotis; Liang Ge; Pengfei Ge; Shengfang Ge; Po-Wu Gean; Vania Gelmetti; Armando A Genazzani; Jiefei Geng; Pascal Genschik; Lisa Gerner; Jason E Gestwicki; David A Gewirtz; Saeid Ghavami; Eric Ghigo; Debabrata Ghosh; Anna Maria Giammarioli; Francesca Giampieri; Claudia Giampietri; Alexandra Giatromanolaki; Derrick J Gibbings; Lara Gibellini; Spencer B Gibson; Vanessa Ginet; Antonio Giordano; Flaviano Giorgini; Elisa Giovannetti; Stephen E Girardin; Suzana Gispert; Sandy Giuliano; Candece L Gladson; Alvaro Glavic; Martin Gleave; Nelly Godefroy; Robert M Gogal; Kuppan Gokulan; Gustavo H Goldman; Delia Goletti; Michael S Goligorsky; Aldrin V Gomes; Ligia C Gomes; Hernando Gomez; Candelaria Gomez-Manzano; Rubén Gómez-Sánchez; Dawit Ap Gonçalves; Ebru Goncu; Qingqiu Gong; Céline Gongora; Carlos B Gonzalez; Pedro Gonzalez-Alegre; Pilar Gonzalez-Cabo; Rosa Ana González-Polo; Ing Swie Goping; Carlos Gorbea; Nikolai V Gorbunov; Daphne R Goring; Adrienne M Gorman; Sharon M Gorski; Sandro Goruppi; Shino Goto-Yamada; Cecilia Gotor; Roberta A Gottlieb; Illana Gozes; Devrim Gozuacik; Yacine Graba; Martin Graef; Giovanna E Granato; Gary Dean Grant; Steven Grant; Giovanni Luca Gravina; Douglas R Green; Alexander Greenhough; Michael T Greenwood; Benedetto Grimaldi; Frédéric Gros; Charles Grose; Jean-Francois Groulx; Florian Gruber; Paolo Grumati; Tilman Grune; Jun-Lin Guan; Kun-Liang Guan; Barbara Guerra; Carlos Guillen; Kailash Gulshan; Jan Gunst; Chuanyong Guo; Lei Guo; Ming Guo; Wenjie Guo; Xu-Guang Guo; Andrea A Gust; Åsa B Gustafsson; Elaine Gutierrez; Maximiliano G Gutierrez; Ho-Shin Gwak; Albert Haas; James E Haber; Shinji Hadano; Monica Hagedorn; David R Hahn; Andrew J Halayko; Anne Hamacher-Brady; Kozo Hamada; Ahmed Hamai; Andrea Hamann; Maho Hamasaki; Isabelle Hamer; Qutayba Hamid; Ester M Hammond; Feng Han; Weidong Han; James T Handa; John A Hanover; Malene Hansen; Masaru Harada; Ljubica Harhaji-Trajkovic; J Wade Harper; Abdel Halim Harrath; Adrian L Harris; James Harris; Udo Hasler; Peter Hasselblatt; Kazuhisa Hasui; Robert G Hawley; Teresa S Hawley; Congcong He; Cynthia Y He; Fengtian He; Gu He; Rong-Rong He; Xian-Hui He; You-Wen He; Yu-Ying He; Joan K Heath; Marie-Josée Hébert; Robert A Heinzen; Gudmundur Vignir Helgason; Michael Hensel; Elizabeth P Henske; Chengtao Her; Paul K Herman; Agustín Hernández; Carlos Hernandez; Sonia Hernández-Tiedra; Claudio Hetz; P Robin Hiesinger; Katsumi Higaki; Sabine Hilfiker; Bradford G Hill; Joseph A Hill; William D Hill; Keisuke Hino; Daniel Hofius; Paul Hofman; Günter U Höglinger; Jörg Höhfeld; Marina K Holz; Yonggeun Hong; David A Hood; Jeroen Jm Hoozemans; Thorsten Hoppe; Chin Hsu; Chin-Yuan Hsu; Li-Chung Hsu; Dong Hu; Guochang Hu; Hong-Ming Hu; Hongbo Hu; Ming Chang Hu; Yu-Chen Hu; Zhuo-Wei Hu; Fang Hua; Ya Hua; Canhua Huang; Huey-Lan Huang; Kuo-How Huang; Kuo-Yang Huang; Shile Huang; Shiqian Huang; Wei-Pang Huang; Yi-Ran Huang; Yong Huang; Yunfei Huang; Tobias B Huber; Patricia Huebbe; Won-Ki Huh; Juha J Hulmi; Gang Min Hur; James H Hurley; Zvenyslava Husak; Sabah Na Hussain; Salik Hussain; Jung Jin Hwang; Seungmin Hwang; Thomas Is Hwang; Atsuhiro Ichihara; Yuzuru Imai; Carol Imbriano; Megumi Inomata; Takeshi Into; Valentina Iovane; Juan L Iovanna; Renato V Iozzo; Nancy Y Ip; Javier E Irazoqui; Pablo Iribarren; Yoshitaka Isaka; Aleksandra J Isakovic; Harry Ischiropoulos; Jeffrey S Isenberg; Mohammad Ishaq; Hiroyuki Ishida; Isao Ishii; Jane E Ishmael; Ciro Isidoro; Ken-Ichi Isobe; Erika Isono; Shohreh Issazadeh-Navikas; Koji Itahana; Eisuke Itakura; Andrei I Ivanov; Anand Krishnan V Iyer; José M Izquierdo; Yotaro Izumi; Valentina Izzo; Marja Jäättelä; Nadia Jaber; Daniel John Jackson; William T Jackson; Tony George Jacob; Thomas S Jacques; Chinnaswamy Jagannath; Ashish Jain; Nihar Ranjan Jana; Byoung Kuk Jang; Alkesh Jani; Bassam Janji; Paulo Roberto Jannig; Patric J Jansson; Steve Jean; Marina Jendrach; Ju-Hong Jeon; Niels Jessen; Eui-Bae Jeung; Kailiang Jia; Lijun Jia; Hong Jiang; Hongchi Jiang; Liwen Jiang; Teng Jiang; Xiaoyan Jiang; Xuejun Jiang; Xuejun Jiang; Ying Jiang; Yongjun Jiang; Alberto Jiménez; Cheng Jin; Hongchuan Jin; Lei Jin; Meiyan Jin; Shengkan Jin; Umesh Kumar Jinwal; Eun-Kyeong Jo; Terje Johansen; Daniel E Johnson; Gail Vw Johnson; James D Johnson; Eric Jonasch; Chris Jones; Leo Ab Joosten; Joaquin Jordan; Anna-Maria Joseph; Bertrand Joseph; Annie M Joubert; Dianwen Ju; Jingfang Ju; Hsueh-Fen Juan; Katrin Juenemann; Gábor Juhász; Hye Seung Jung; Jae U Jung; Yong-Keun Jung; Heinz Jungbluth; Matthew J Justice; Barry Jutten; Nadeem O Kaakoush; Kai Kaarniranta; Allen Kaasik; Tomohiro Kabuta; Bertrand Kaeffer; Katarina Kågedal; Alon Kahana; Shingo Kajimura; Or Kakhlon; Manjula Kalia; Dhan V Kalvakolanu; Yoshiaki Kamada; Konstantinos Kambas; Vitaliy O Kaminskyy; Harm H Kampinga; Mustapha Kandouz; Chanhee Kang; Rui Kang; Tae-Cheon Kang; Tomotake Kanki; Thirumala-Devi Kanneganti; Haruo Kanno; Anumantha G Kanthasamy; Marc Kantorow; Maria Kaparakis-Liaskos; Orsolya Kapuy; Vassiliki Karantza; Md Razaul Karim; Parimal Karmakar; Arthur Kaser; Susmita Kaushik; Thomas Kawula; A Murat Kaynar; Po-Yuan Ke; Zun-Ji Ke; John H Kehrl; Kate E Keller; Jongsook Kim Kemper; Anne K Kenworthy; Oliver Kepp; Andreas Kern; Santosh Kesari; David Kessel; Robin Ketteler; Isis do Carmo Kettelhut; Bilon Khambu; Muzamil Majid Khan; Vinoth Km Khandelwal; Sangeeta Khare; Juliann G Kiang; Amy A Kiger; Akio Kihara; Arianna L Kim; Cheol Hyeon Kim; Deok Ryong Kim; Do-Hyung Kim; Eung Kweon Kim; Hye Young Kim; Hyung-Ryong Kim; Jae-Sung Kim; Jeong Hun Kim; Jin Cheon Kim; Jin Hyoung Kim; Kwang Woon Kim; Michael D Kim; Moon-Moo Kim; Peter K Kim; Seong Who Kim; Soo-Youl Kim; Yong-Sun Kim; Yonghyun Kim; Adi Kimchi; Alec C Kimmelman; Tomonori Kimura; Jason S King; Karla Kirkegaard; Vladimir Kirkin; Lorrie A Kirshenbaum; Shuji Kishi; Yasuo Kitajima; Katsuhiko Kitamoto; Yasushi Kitaoka; Kaio Kitazato; Rudolf A Kley; Walter T Klimecki; Michael Klinkenberg; Jochen Klucken; Helene Knævelsrud; Erwin Knecht; Laura Knuppertz; Jiunn-Liang Ko; Satoru Kobayashi; Jan C Koch; Christelle Koechlin-Ramonatxo; Ulrich Koenig; Young Ho Koh; Katja Köhler; Sepp D Kohlwein; Masato Koike; Masaaki Komatsu; Eiki Kominami; Dexin Kong; Hee Jeong Kong; Eumorphia G Konstantakou; Benjamin T Kopp; Tamas Korcsmaros; Laura Korhonen; Viktor I Korolchuk; Nadya V Koshkina; Yanjun Kou; Michael I Koukourakis; Constantinos Koumenis; Attila L Kovács; Tibor Kovács; Werner J Kovacs; Daisuke Koya; Claudine Kraft; Dimitri Krainc; Helmut Kramer; Tamara Kravic-Stevovic; Wilhelm Krek; Carole Kretz-Remy; Roswitha Krick; Malathi Krishnamurthy; Janos Kriston-Vizi; Guido Kroemer; Michael C Kruer; Rejko Kruger; Nicholas T Ktistakis; Kazuyuki Kuchitsu; Christian Kuhn; Addanki Pratap Kumar; Anuj Kumar; Ashok Kumar; Deepak Kumar; Dhiraj Kumar; Rakesh Kumar; Sharad Kumar; Mondira Kundu; Hsing-Jien Kung; Atsushi Kuno; Sheng-Han Kuo; Jeff Kuret; Tino Kurz; Terry Kwok; Taeg Kyu Kwon; Yong Tae Kwon; Irene Kyrmizi; Albert R La Spada; Frank Lafont; Tim Lahm; Aparna Lakkaraju; Truong Lam; Trond Lamark; Steve Lancel; Terry H Landowski; Darius J R Lane; Jon D Lane; Cinzia Lanzi; Pierre Lapaquette; Louis R Lapierre; Jocelyn Laporte; Johanna Laukkarinen; Gordon W Laurie; Sergio Lavandero; Lena Lavie; Matthew J LaVoie; Betty Yuen Kwan Law; Helen Ka-Wai Law; Kelsey B Law; Robert Layfield; Pedro A Lazo; Laurent Le Cam; Karine G Le Roch; Hervé Le Stunff; Vijittra Leardkamolkarn; Marc Lecuit; Byung-Hoon Lee; Che-Hsin Lee; Erinna F Lee; Gyun Min Lee; He-Jin Lee; Hsinyu Lee; Jae Keun Lee; Jongdae Lee; Ju-Hyun Lee; Jun Hee Lee; Michael Lee; Myung-Shik Lee; Patty J Lee; Sam W Lee; Seung-Jae Lee; Shiow-Ju Lee; Stella Y Lee; Sug Hyung Lee; Sung Sik Lee; Sung-Joon Lee; Sunhee Lee; Ying-Ray Lee; Yong J Lee; Young H Lee; Christiaan Leeuwenburgh; Sylvain Lefort; Renaud Legouis; Jinzhi Lei; Qun-Ying Lei; David A Leib; Gil Leibowitz; Istvan Lekli; Stéphane D Lemaire; John J Lemasters; Marius K Lemberg; Antoinette Lemoine; Shuilong Leng; Guido Lenz; Paola Lenzi; Lilach O Lerman; Daniele Lettieri Barbato; Julia I-Ju Leu; Hing Y Leung; Beth Levine; Patrick A Lewis; Frank Lezoualc'h; Chi Li; Faqiang Li; Feng-Jun Li; Jun Li; Ke Li; Lian Li; Min Li; Min Li; Qiang Li; Rui Li; Sheng Li; Wei Li; Wei Li; Xiaotao Li; Yumin Li; Jiqin Lian; Chengyu Liang; Qiangrong Liang; Yulin Liao; Joana Liberal; Pawel P Liberski; Pearl Lie; Andrew P Lieberman; Hyunjung Jade Lim; Kah-Leong Lim; Kyu Lim; Raquel T Lima; Chang-Shen Lin; Chiou-Feng Lin; Fang Lin; Fangming Lin; Fu-Cheng Lin; Kui Lin; Kwang-Huei Lin; Pei-Hui Lin; Tianwei Lin; Wan-Wan Lin; Yee-Shin Lin; Yong Lin; Rafael Linden; Dan Lindholm; Lisa M Lindqvist; Paul Lingor; Andreas Linkermann; Lance A Liotta; Marta M Lipinski; Vitor A Lira; Michael P Lisanti; Paloma B Liton; Bo Liu; Chong Liu; Chun-Feng Liu; Fei Liu; Hung-Jen Liu; Jianxun Liu; Jing-Jing Liu; Jing-Lan Liu; Ke Liu; Leyuan Liu; Liang Liu; Quentin Liu; Rong-Yu Liu; Shiming Liu; Shuwen Liu; Wei Liu; Xian-De Liu; Xiangguo Liu; Xiao-Hong Liu; Xinfeng Liu; Xu Liu; Xueqin Liu; Yang Liu; Yule Liu; Zexian Liu; Zhe Liu; Juan P Liuzzi; Gérard Lizard; Mila Ljujic; Irfan J Lodhi; Susan E Logue; Bal L Lokeshwar; Yun Chau Long; Sagar Lonial; Benjamin Loos; Carlos López-Otín; Cristina López-Vicario; Mar Lorente; Philip L Lorenzi; Péter Lõrincz; Marek Los; Michael T Lotze; Penny E Lovat; Binfeng Lu; Bo Lu; Jiahong Lu; Qing Lu; She-Min Lu; Shuyan Lu; Yingying Lu; Frédéric Luciano; Shirley Luckhart; John Milton Lucocq; Paula Ludovico; Aurelia Lugea; Nicholas W Lukacs; Julian J Lum; Anders H Lund; Honglin Luo; Jia Luo; Shouqing Luo; Claudio Luparello; Timothy Lyons; Jianjie Ma; Yi Ma; Yong Ma; Zhenyi Ma; Juliano Machado; Glaucia M Machado-Santelli; Fernando Macian; Gustavo C MacIntosh; Jeffrey P MacKeigan; Kay F Macleod; John D MacMicking; Lee Ann MacMillan-Crow; Frank Madeo; Muniswamy Madesh; Julio Madrigal-Matute; Akiko Maeda; Tatsuya Maeda; Gustavo Maegawa; Emilia Maellaro; Hannelore Maes; Marta Magariños; Kenneth Maiese; Tapas K Maiti; Luigi Maiuri; Maria Chiara Maiuri; Carl G Maki; Roland Malli; Walter Malorni; Alina Maloyan; Fathia Mami-Chouaib; Na Man; Joseph D Mancias; Eva-Maria Mandelkow; Michael A Mandell; Angelo A Manfredi; Serge N Manié; Claudia Manzoni; Kai Mao; Zixu Mao; Zong-Wan Mao; Philippe Marambaud; Anna Maria Marconi; Zvonimir Marelja; Gabriella Marfe; Marta Margeta; Eva Margittai; Muriel Mari; Francesca V Mariani; Concepcio Marin; Sara Marinelli; Guillermo Mariño; Ivanka Markovic; Rebecca Marquez; Alberto M Martelli; Sascha Martens; Katie R Martin; Seamus J Martin; Shaun Martin; Miguel A Martin-Acebes; Paloma Martín-Sanz; Camille Martinand-Mari; Wim Martinet; Jennifer Martinez; Nuria Martinez-Lopez; Ubaldo Martinez-Outschoorn; Moisés Martínez-Velázquez; Marta Martinez-Vicente; Waleska Kerllen Martins; Hirosato Mashima; James A Mastrianni; Giuseppe Matarese; Paola Matarrese; Roberto Mateo; Satoaki Matoba; Naomichi Matsumoto; Takehiko Matsushita; Akira Matsuura; Takeshi Matsuzawa; Mark P Mattson; Soledad Matus; Norma Maugeri; Caroline Mauvezin; Andreas Mayer; Dusica Maysinger; Guillermo D Mazzolini; Mary Kate McBrayer; Kimberly McCall; Craig McCormick; Gerald M McInerney; Skye C McIver; Sharon McKenna; John J McMahon; Iain A McNeish; Fatima Mechta-Grigoriou; Jan Paul Medema; Diego L Medina; Klara Megyeri; Maryam Mehrpour; Jawahar L Mehta; Yide Mei; Ute-Christiane Meier; Alfred J Meijer; Alicia Meléndez; Gerry Melino; Sonia Melino; Edesio Jose Tenorio de Melo; Maria A Mena; Marc D Meneghini; Javier A Menendez; Regina Menezes; Liesu Meng; Ling-Hua Meng; Songshu Meng; Rossella Menghini; A Sue Menko; Rubem Fs Menna-Barreto; Manoj B Menon; Marco A Meraz-Ríos; Giuseppe Merla; Luciano Merlini; Angelica M Merlot; Andreas Meryk; Stefania Meschini; Joel N Meyer; Man-Tian Mi; Chao-Yu Miao; Lucia Micale; Simon Michaeli; Carine Michiels; Anna Rita Migliaccio; Anastasia Susie Mihailidou; Dalibor Mijaljica; Katsuhiko Mikoshiba; Enrico Milan; Leonor Miller-Fleming; Gordon B Mills; Ian G Mills; Georgia Minakaki; Berge A Minassian; Xiu-Fen Ming; Farida Minibayeva; Elena A Minina; Justine D Mintern; Saverio Minucci; Antonio Miranda-Vizuete; Claire H Mitchell; Shigeki Miyamoto; Keisuke Miyazawa; Noboru Mizushima; Katarzyna Mnich; Baharia Mograbi; Simin Mohseni; Luis Ferreira Moita; Marco Molinari; Maurizio Molinari; Andreas Buch Møller; Bertrand Mollereau; Faustino Mollinedo; Marco Mongillo; Martha M Monick; Serena Montagnaro; Craig Montell; Darren J Moore; Michael N Moore; Rodrigo Mora-Rodriguez; Paula I Moreira; Etienne Morel; Maria Beatrice Morelli; Sandra Moreno; Michael J Morgan; Arnaud Moris; Yuji Moriyasu; Janna L Morrison; Lynda A Morrison; Eugenia Morselli; Jorge Moscat; Pope L Moseley; Serge Mostowy; Elisa Motori; Denis Mottet; Jeremy C Mottram; Charbel E-H Moussa; Vassiliki E Mpakou; Hasan Mukhtar; Jean M Mulcahy Levy; Sylviane Muller; Raquel Muñoz-Moreno; Cristina Muñoz-Pinedo; Christian Münz; Maureen E Murphy; James T Murray; Aditya Murthy; Indira U Mysorekar; Ivan R Nabi; Massimo Nabissi; Gustavo A Nader; Yukitoshi Nagahara; Yoshitaka Nagai; Kazuhiro Nagata; Anika Nagelkerke; Péter Nagy; Samisubbu R Naidu; Sreejayan Nair; Hiroyasu Nakano; Hitoshi Nakatogawa; Meera Nanjundan; Gennaro Napolitano; Naweed I Naqvi; Roberta Nardacci; Derek P Narendra; Masashi Narita; Anna Chiara Nascimbeni; Ramesh Natarajan; Luiz C Navegantes; Steffan T Nawrocki; Taras Y Nazarko; Volodymyr Y Nazarko; Thomas Neill; Luca M Neri; Mihai G Netea; Romana T Netea-Maier; Bruno M Neves; Paul A Ney; Ioannis P Nezis; Hang Tt Nguyen; Huu Phuc Nguyen; Anne-Sophie Nicot; Hilde Nilsen; Per Nilsson; Mikio Nishimura; Ichizo Nishino; Mireia Niso-Santano; Hua Niu; Ralph A Nixon; Vincent Co Njar; Takeshi Noda; Angelika A Noegel; Elsie Magdalena Nolte; Erik Norberg; Koenraad K Norga; Sakineh Kazemi Noureini; Shoji Notomi; Lucia Notterpek; Karin Nowikovsky; Nobuyuki Nukina; Thorsten Nürnberger; Valerie B O'Donnell; Tracey O'Donovan; Peter J O'Dwyer; Ina Oehme; Clara L Oeste; Michinaga Ogawa; Besim Ogretmen; Yuji Ogura; Young J Oh; Masaki Ohmuraya; Takayuki Ohshima; Rani Ojha; Koji Okamoto; Toshiro Okazaki; F Javier Oliver; Karin Ollinger; Stefan Olsson; Daniel P Orban; Paulina Ordonez; Idil Orhon; Laszlo Orosz; Eyleen J O'Rourke; Helena Orozco; Angel L Ortega; Elena Ortona; Laura D Osellame; Junko Oshima; Shigeru Oshima; Heinz D Osiewacz; Takanobu Otomo; Kinya Otsu; Jing-Hsiung James Ou; Tiago F Outeiro; Dong-Yun Ouyang; Hongjiao Ouyang; Michael Overholtzer; Michelle A Ozbun; P Hande Ozdinler; Bulent Ozpolat; Consiglia Pacelli; Paolo Paganetti; Guylène Page; Gilles Pages; Ugo Pagnini; Beata Pajak; Stephen C Pak; Karolina Pakos-Zebrucka; Nazzy Pakpour; Zdena Palková; Francesca Palladino; Kathrin Pallauf; Nicolas Pallet; Marta Palmieri; Søren R Paludan; Camilla Palumbo; Silvia Palumbo; Olatz Pampliega; Hongming Pan; Wei Pan; Theocharis Panaretakis; Aseem Pandey; Areti Pantazopoulou; Zuzana Papackova; Daniela L Papademetrio; Issidora Papassideri; Alessio Papini; Nirmala Parajuli; Julian Pardo; Vrajesh V Parekh; Giancarlo Parenti; Jong-In Park; Junsoo Park; Ohkmae K Park; Roy Parker; Rosanna Parlato; Jan B Parys; Katherine R Parzych; Jean-Max Pasquet; Benoit Pasquier; Kishore Bs Pasumarthi; Daniel Patschan; Cam Patterson; Sophie Pattingre; Scott Pattison; Arnim Pause; Hermann Pavenstädt; Flaminia Pavone; Zully Pedrozo; Fernando J Peña; Miguel A Peñalva; Mario Pende; Jianxin Peng; Fabio Penna; Josef M Penninger; Anna Pensalfini; Salvatore Pepe; Gustavo Js Pereira; Paulo C Pereira; Verónica Pérez-de la Cruz; María Esther Pérez-Pérez; Diego Pérez-Rodríguez; Dolores Pérez-Sala; Celine Perier; Andras Perl; David H Perlmutter; Ida Perrotta; Shazib Pervaiz; Maija Pesonen; Jeffrey E Pessin; Godefridus J Peters; Morten Petersen; Irina Petrache; Basil J Petrof; Goran Petrovski; James M Phang; Mauro Piacentini; Marina Pierdominici; Philippe Pierre; Valérie Pierrefite-Carle; Federico Pietrocola; Felipe X Pimentel-Muiños; Mario Pinar; Benjamin Pineda; Ronit Pinkas-Kramarski; Marcello Pinti; Paolo Pinton; Bilal Piperdi; James M Piret; Leonidas C Platanias; Harald W Platta; Edward D Plowey; Stefanie Pöggeler; Marc Poirot; Peter Polčic; Angelo Poletti; Audrey H Poon; Hana Popelka; Blagovesta Popova; Izabela Poprawa; Shibu M Poulose; Joanna Poulton; Scott K Powers; Ted Powers; Mercedes Pozuelo-Rubio; Krisna Prak; Reinhild Prange; Mark Prescott; Muriel Priault; Sharon Prince; Richard L Proia; Tassula Proikas-Cezanne; Holger Prokisch; Vasilis J Promponas; Karin Przyklenk; Rosa Puertollano; Subbiah Pugazhenthi; Luigi Puglielli; Aurora Pujol; Julien Puyal; Dohun Pyeon; Xin Qi; Wen-Bin Qian; Zheng-Hong Qin; Yu Qiu; Ziwei Qu; Joe Quadrilatero; Frederick Quinn; Nina Raben; Hannah Rabinowich; Flavia Radogna; Michael J Ragusa; Mohamed Rahmani; Komal Raina; Sasanka Ramanadham; Rajagopal Ramesh; Abdelhaq Rami; Sarron Randall-Demllo; Felix Randow; Hai Rao; V Ashutosh Rao; Blake B Rasmussen; Tobias M Rasse; Edward A Ratovitski; Pierre-Emmanuel Rautou; Swapan K Ray; Babak Razani; Bruce H Reed; Fulvio Reggiori; Markus Rehm; Andreas S Reichert; Theo Rein; David J Reiner; Eric Reits; Jun Ren; Xingcong Ren; Maurizio Renna; Jane Eb Reusch; Jose L Revuelta; Leticia Reyes; Alireza R Rezaie; Robert I Richards; Des R Richardson; Clémence Richetta; Michael A Riehle; Bertrand H Rihn; Yasuko Rikihisa; Brigit E Riley; Gerald Rimbach; Maria Rita Rippo; Konstantinos Ritis; Federica Rizzi; Elizete Rizzo; Peter J Roach; Jeffrey Robbins; Michel Roberge; Gabriela Roca; Maria Carmela Roccheri; Sonia Rocha; Cecilia Mp Rodrigues; Clara I Rodríguez; Santiago Rodriguez de Cordoba; Natalia Rodriguez-Muela; Jeroen Roelofs; Vladimir V Rogov; Troy T Rohn; Bärbel Rohrer; Davide Romanelli; Luigina Romani; Patricia Silvia Romano; M Isabel G Roncero; Jose Luis Rosa; Alicia Rosello; Kirill V Rosen; Philip Rosenstiel; Magdalena Rost-Roszkowska; Kevin A Roth; Gael Roué; Mustapha Rouis; Kasper M Rouschop; Daniel T Ruan; Diego Ruano; David C Rubinsztein; Edmund B Rucker; Assaf Rudich; Emil Rudolf; Ruediger Rudolf; Markus A Ruegg; Carmen Ruiz-Roldan; Avnika Ashok Ruparelia; Paola Rusmini; David W Russ; Gian Luigi Russo; Giuseppe Russo; Rossella Russo; Tor Erik Rusten; Victoria Ryabovol; Kevin M Ryan; Stefan W Ryter; David M Sabatini; Michael Sacher; Carsten Sachse; Michael N Sack; Junichi Sadoshima; Paul Saftig; Ronit Sagi-Eisenberg; Sumit Sahni; Pothana Saikumar; Tsunenori Saito; Tatsuya Saitoh; Koichi Sakakura; Machiko Sakoh-Nakatogawa; Yasuhito Sakuraba; María Salazar-Roa; Paolo Salomoni; Ashok K Saluja; Paul M Salvaterra; Rosa Salvioli; Afshin Samali; Anthony Mj Sanchez; José A Sánchez-Alcázar; Ricardo Sanchez-Prieto; Marco Sandri; Miguel A Sanjuan; Stefano Santaguida; Laura Santambrogio; Giorgio Santoni; Claudia Nunes Dos Santos; Shweta Saran; Marco Sardiello; Graeme Sargent; Pallabi Sarkar; Sovan Sarkar; Maria Rosa Sarrias; Minnie M Sarwal; Chihiro Sasakawa; Motoko Sasaki; Miklos Sass; Ken Sato; Miyuki Sato; Joseph Satriano; Niramol Savaraj; Svetlana Saveljeva; Liliana Schaefer; Ulrich E Schaible; Michael Scharl; Hermann M Schatzl; Randy Schekman; Wiep Scheper; Alfonso Schiavi; Hyman M Schipper; Hana Schmeisser; Jens Schmidt; Ingo Schmitz; Bianca E Schneider; E Marion Schneider; Jaime L Schneider; Eric A Schon; Miriam J Schönenberger; Axel H Schönthal; Daniel F Schorderet; Bernd Schröder; Sebastian Schuck; Ryan J Schulze; Melanie Schwarten; Thomas L Schwarz; Sebastiano Sciarretta; Kathleen Scotto; A Ivana Scovassi; Robert A Screaton; Mark Screen; Hugo Seca; Simon Sedej; Laura Segatori; Nava Segev; Per O Seglen; Jose M Seguí-Simarro; Juan Segura-Aguilar; Ekihiro Seki; Christian Sell; Iban Seiliez; Clay F Semenkovich; Gregg L Semenza; Utpal Sen; Andreas L Serra; Ana Serrano-Puebla; Hiromi Sesaki; Takao Setoguchi; Carmine Settembre; John J Shacka; Ayesha N Shajahan-Haq; Irving M Shapiro; Shweta Sharma; Hua She; C-K James Shen; Chiung-Chyi Shen; Han-Ming Shen; Sanbing Shen; Weili Shen; Rui Sheng; Xianyong Sheng; Zu-Hang Sheng; Trevor G Shepherd; Junyan Shi; Qiang Shi; Qinghua Shi; Yuguang Shi; Shusaku Shibutani; Kenichi Shibuya; Yoshihiro Shidoji; Jeng-Jer Shieh; Chwen-Ming Shih; Yohta Shimada; Shigeomi Shimizu; Dong Wook Shin; Mari L Shinohara; Michiko Shintani; Takahiro Shintani; Tetsuo Shioi; Ken Shirabe; Ronit Shiri-Sverdlov; Orian Shirihai; Gordon C Shore; Chih-Wen Shu; Deepak Shukla; Andriy A Sibirny; Valentina Sica; Christina J Sigurdson; Einar M Sigurdsson; Puran Singh Sijwali; Beata Sikorska; Wilian A Silveira; Sandrine Silvente-Poirot; Gary A Silverman; Jan Simak; Thomas Simmet; Anna Katharina Simon; Hans-Uwe Simon; Cristiano Simone; Matias Simons; Anne Simonsen; Rajat Singh; Shivendra V Singh; Shrawan K Singh; Debasish Sinha; Sangita Sinha; Frank A Sinicrope; Agnieszka Sirko; Kapil Sirohi; Balindiwe Jn Sishi; Annie Sittler; Parco M Siu; Efthimios Sivridis; Anna Skwarska; Ruth Slack; Iva Slaninová; Nikolai Slavov; Soraya S Smaili; Keiran Sm Smalley; Duncan R Smith; Stefaan J Soenen; Scott A Soleimanpour; Anita Solhaug; Kumaravel Somasundaram; Jin H Son; Avinash Sonawane; Chunjuan Song; Fuyong Song; Hyun Kyu Song; Ju-Xian Song; Wei Song; Kai Y Soo; Anil K Sood; Tuck Wah Soong; Virawudh Soontornniyomkij; Maurizio Sorice; Federica Sotgia; David R Soto-Pantoja; Areechun Sotthibundhu; Maria João Sousa; Herman P Spaink; Paul N Span; Anne Spang; Janet D Sparks; Peter G Speck; Stephen A Spector; Claudia D Spies; Wolfdieter Springer; Daret St Clair; Alessandra Stacchiotti; Bart Staels; Michael T Stang; Daniel T Starczynowski; Petro Starokadomskyy; Clemens Steegborn; John W Steele; Leonidas Stefanis; Joan Steffan; Christine M Stellrecht; Harald Stenmark; Tomasz M Stepkowski; Stęphan T Stern; Craig Stevens; Brent R Stockwell; Veronika Stoka; Zuzana Storchova; Björn Stork; Vassilis Stratoulias; Dimitrios J Stravopodis; Pavel Strnad; Anne Marie Strohecker; Anna-Lena Ström; Per Stromhaug; Jiri Stulik; Yu-Xiong Su; Zhaoliang Su; Carlos S Subauste; Srinivasa Subramaniam; Carolyn M Sue; Sang Won Suh; Xinbing Sui; Supawadee Sukseree; David Sulzer; Fang-Lin Sun; Jiaren Sun; Jun Sun; Shi-Yong Sun; Yang Sun; Yi Sun; Yingjie Sun; Vinod Sundaramoorthy; Joseph Sung; Hidekazu Suzuki; Kuninori Suzuki; Naoki Suzuki; Tadashi Suzuki; Yuichiro J Suzuki; Michele S Swanson; Charles Swanton; Karl Swärd; Ghanshyam Swarup; Sean T Sweeney; Paul W Sylvester; Zsuzsanna Szatmari; Eva Szegezdi; Peter W Szlosarek; Heinrich Taegtmeyer; Marco Tafani; Emmanuel Taillebourg; Stephen Wg Tait; Krisztina Takacs-Vellai; Yoshinori Takahashi; Szabolcs Takáts; Genzou Takemura; Nagio Takigawa; Nicholas J Talbot; Elena Tamagno; Jerome Tamburini; Cai-Ping Tan; Lan Tan; Mei Lan Tan; Ming Tan; Yee-Joo Tan; Keiji Tanaka; Masaki Tanaka; Daolin Tang; Dingzhong Tang; Guomei Tang; Isei Tanida; Kunikazu Tanji; Bakhos A Tannous; Jose A Tapia; Inmaculada Tasset-Cuevas; Marc Tatar; Iman Tavassoly; Nektarios Tavernarakis; Allen Taylor; Graham S Taylor; Gregory A Taylor; J Paul Taylor; Mark J Taylor; Elena V Tchetina; Andrew R Tee; Fatima Teixeira-Clerc; Sucheta Telang; Tewin Tencomnao; Ba-Bie Teng; Ru-Jeng Teng; Faraj Terro; Gianluca Tettamanti; Arianne L Theiss; Anne E Theron; Kelly Jean Thomas; Marcos P Thomé; Paul G Thomes; Andrew Thorburn; Jeremy Thorner; Thomas Thum; Michael Thumm; Teresa Lm Thurston; Ling Tian; Andreas Till; Jenny Pan-Yun Ting; Vladimir I Titorenko; Lilach Toker; Stefano Toldo; Sharon A Tooze; Ivan Topisirovic; Maria Lyngaas Torgersen; Liliana Torosantucci; Alicia Torriglia; Maria Rosaria Torrisi; Cathy Tournier; Roberto Towns; Vladimir Trajkovic; Leonardo H Travassos; Gemma Triola; Durga Nand Tripathi; Daniela Trisciuoglio; Rodrigo Troncoso; Ioannis P Trougakos; Anita C Truttmann; Kuen-Jer Tsai; Mario P Tschan; Yi-Hsin Tseng; Takayuki Tsukuba; Allan Tsung; Andrey S Tsvetkov; Shuiping Tu; Hsing-Yu Tuan; Marco Tucci; David A Tumbarello; Boris Turk; Vito Turk; Robin Fb Turner; Anders A Tveita; Suresh C Tyagi; Makoto Ubukata; Yasuo Uchiyama; Andrej Udelnow; Takashi Ueno; Midori Umekawa; Rika Umemiya-Shirafuji; Benjamin R Underwood; Christian Ungermann; Rodrigo P Ureshino; Ryo Ushioda; Vladimir N Uversky; Néstor L Uzcátegui; Thomas Vaccari; Maria I Vaccaro; Libuše Váchová; Helin Vakifahmetoglu-Norberg; Rut Valdor; Enza Maria Valente; Francois Vallette; Angela M Valverde; Greet Van den Berghe; Ludo Van Den Bosch; Gijs R van den Brink; F Gisou van der Goot; Ida J van der Klei; Luc Jw van der Laan; Wouter G van Doorn; Marjolein van Egmond; Kenneth L van Golen; Luc Van Kaer; Menno van Lookeren Campagne; Peter Vandenabeele; Wim Vandenberghe; Ilse Vanhorebeek; Isabel Varela-Nieto; M Helena Vasconcelos; Radovan Vasko; Demetrios G Vavvas; Ignacio Vega-Naredo; Guillermo Velasco; Athanassios D Velentzas; Panagiotis D Velentzas; Tibor Vellai; Edo Vellenga; Mikkel Holm Vendelbo; Kartik Venkatachalam; Natascia Ventura; Salvador Ventura; Patrícia St Veras; Mireille Verdier; Beata G Vertessy; Andrea Viale; Michel Vidal; Helena L A Vieira; Richard D Vierstra; Nadarajah Vigneswaran; Neeraj Vij; Miquel Vila; Margarita Villar; Victor H Villar; Joan Villarroya; Cécile Vindis; Giampietro Viola; Maria Teresa Viscomi; Giovanni Vitale; Dan T Vogl; Olga V Voitsekhovskaja; Clarissa von Haefen; Karin von Schwarzenberg; Daniel E Voth; Valérie Vouret-Craviari; Kristina Vuori; Jatin M Vyas; Christian Waeber; Cheryl Lyn Walker; Mark J Walker; Jochen Walter; Lei Wan; Xiangbo Wan; Bo Wang; Caihong Wang; Chao-Yung Wang; Chengshu Wang; Chenran Wang; Chuangui Wang; Dong Wang; Fen Wang; Fuxin Wang; Guanghui Wang; Hai-Jie Wang; Haichao Wang; Hong-Gang Wang; Hongmin Wang; Horng-Dar Wang; Jing Wang; Junjun Wang; Mei Wang; Mei-Qing Wang; Pei-Yu Wang; Peng Wang; Richard C Wang; Shuo Wang; Ting-Fang Wang; Xian Wang; Xiao-Jia Wang; Xiao-Wei Wang; Xin Wang; Xuejun Wang; Yan Wang; Yanming Wang; Ying Wang; Ying-Jan Wang; Yipeng Wang; Yu Wang; Yu Tian Wang; Yuqing Wang; Zhi-Nong Wang; Pablo Wappner; Carl Ward; Diane McVey Ward; Gary Warnes; Hirotaka Watada; Yoshihisa Watanabe; Kei Watase; Timothy E Weaver; Colin D Weekes; Jiwu Wei; Thomas Weide; Conrad C Weihl; Günther Weindl; Simone Nardin Weis; Longping Wen; Xin Wen; Yunfei Wen; Benedikt Westermann; Cornelia M Weyand; Anthony R White; Eileen White; J Lindsay Whitton; Alexander J Whitworth; Joëlle Wiels; Franziska Wild; Manon E Wildenberg; Tom Wileman; Deepti Srinivas Wilkinson; Simon Wilkinson; Dieter Willbold; Chris Williams; Katherine Williams; Peter R Williamson; Konstanze F Winklhofer; Steven S Witkin; Stephanie E Wohlgemuth; Thomas Wollert; Ernst J Wolvetang; Esther Wong; G William Wong; Richard W Wong; Vincent Kam Wai Wong; Elizabeth A Woodcock; Karen L Wright; Chunlai Wu; Defeng Wu; Gen Sheng Wu; Jian Wu; Junfang Wu; Mian Wu; Min Wu; Shengzhou Wu; William Kk Wu; Yaohua Wu; Zhenlong Wu; Cristina Pr Xavier; Ramnik J Xavier; Gui-Xian Xia; Tian Xia; Weiliang Xia; Yong Xia; Hengyi Xiao; Jian Xiao; Shi Xiao; Wuhan Xiao; Chuan-Ming Xie; Zhiping Xie; Zhonglin Xie; Maria Xilouri; Yuyan Xiong; Chuanshan Xu; Congfeng Xu; Feng Xu; Haoxing Xu; Hongwei Xu; Jian Xu; Jianzhen Xu; Jinxian Xu; Liang Xu; Xiaolei Xu; Yangqing Xu; Ye Xu; Zhi-Xiang Xu; Ziheng Xu; Yu Xue; Takahiro Yamada; Ai Yamamoto; Koji Yamanaka; Shunhei Yamashina; Shigeko Yamashiro; Bing Yan; Bo Yan; Xianghua Yan; Zhen Yan; Yasuo Yanagi; Dun-Sheng Yang; Jin-Ming Yang; Liu Yang; Minghua Yang; Pei-Ming Yang; Peixin Yang; Qian Yang; Wannian Yang; Wei Yuan Yang; Xuesong Yang; Yi Yang; Ying Yang; Zhifen Yang; Zhihong Yang; Meng-Chao Yao; Pamela J Yao; Xiaofeng Yao; Zhenyu Yao; Zhiyuan Yao; Linda S Yasui; Mingxiang Ye; Barry Yedvobnick; Behzad Yeganeh; Elizabeth S Yeh; Patricia L Yeyati; Fan Yi; Long Yi; Xiao-Ming Yin; Calvin K Yip; Yeong-Min Yoo; Young Hyun Yoo; Seung-Yong Yoon; Ken-Ichi Yoshida; Tamotsu Yoshimori; Ken H Young; Huixin Yu; Jane J Yu; Jin-Tai Yu; Jun Yu; Li Yu; W Haung Yu; Xiao-Fang Yu; Zhengping Yu; Junying Yuan; Zhi-Min Yuan; Beatrice Yjt Yue; Jianbo Yue; Zhenyu Yue; David N Zacks; Eldad Zacksenhaus; Nadia Zaffaroni; Tania Zaglia; Zahra Zakeri; Vincent Zecchini; Jinsheng Zeng; Min Zeng; Qi Zeng; Antonis S Zervos; Donna D Zhang; Fan Zhang; Guo Zhang; Guo-Chang Zhang; Hao Zhang; Hong Zhang; Hong Zhang; Hongbing Zhang; Jian Zhang; Jian Zhang; Jiangwei Zhang; Jianhua Zhang; Jing-Pu Zhang; Li Zhang; Lin Zhang; Lin Zhang; Long Zhang; Ming-Yong Zhang; Xiangnan Zhang; Xu Dong Zhang; Yan Zhang; Yang Zhang; Yanjin Zhang; Yingmei Zhang; Yunjiao Zhang; Mei Zhao; Wei-Li Zhao; Xiaonan Zhao; Yan G Zhao; Ying Zhao; Yongchao Zhao; Yu-Xia Zhao; Zhendong Zhao; Zhizhuang J Zhao; Dexian Zheng; Xi-Long Zheng; Xiaoxiang Zheng; Boris Zhivotovsky; Qing Zhong; Guang-Zhou Zhou; Guofei Zhou; Huiping Zhou; Shu-Feng Zhou; Xu-Jie Zhou; Hongxin Zhu; Hua Zhu; Wei-Guo Zhu; Wenhua Zhu; Xiao-Feng Zhu; Yuhua Zhu; Shi-Mei Zhuang; Xiaohong Zhuang; Elio Ziparo; Christos E Zois; Teresa Zoladek; Wei-Xing Zong; Antonio Zorzano; Susu M Zughaier Journal: Autophagy Date: 2016 Impact factor: 16.016
Figure 1.
Figure 2.
Figure 3.
Figure 4.
Figure 5 (see previous page).
Figure 6.